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A B S T R A C T
Background
Inpatient treatment is an expensive way of caring for people with acute psychiatric disorders. It has been proposed that many of those
currently treated as inpatients could be cared for in acute psychiatric day hospitals.
Objectives
To assess the effects of day hospital versus inpatient care for people with acute psychiatric disorders.
Search strategy
We searched theCochrane Controlled Trials Register (Cochrane Library, issue 4, 2000), MEDLINE (January 1966 toDecember 2000),
EMBASE (1980 to December 2000), CINAHL (1982 to December 2000), PsycLIT (1966 to December 2000), and the reference lists
of articles. We approached trialists to identify unpublished studies.
Selection criteria
Randomised controlled trials of day hospital versus inpatient care, for people with acute psychiatric disorders. Studies were ineligible
if a majority of participants were under 18 or over 65, or had a primary diagnosis of substance abuse or organic brain disorder.
Data collection and analysis
Data were extracted independently by two reviewers and cross-checked. Relative risks and 95% confidence intervals (CI) were calculated
for dichotomous data. Weighted or standardised means were calculated for continuous data. Day hospital trials tend to present similar
outcomes in slightly different formats, making it difficult to synthesise data. Individual patient data were therefore sought so that
outcomes could be reanalysed in a common format.
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Main results
Nine trials (involving 1568 people) met the inclusion criteria. Individual patient data were obtained for four trials (involving 594
people). Combined data suggested that, at the most pessimistic estimate, day hospital treatment was feasible for 23% (n=2268, CI 21
to 25) of those currently admitted to inpatient care. Individual patient data from three trials showed no difference in number of days in
hospital between day hospital patients and controls (n=465, 3 RCTs, WMD -0.38 days/month CI -1.32 to 0.55). However, compared
to controls, people randomised to day hospital care spent significantly more days in day hospital care (n=265, 3 RCTs, WMD 2.34 days/
month CI 1.97 to 2.70) and significantly fewer days in inpatient care (n=265, 3 RCTs, WMD -2.75 days/month CI -3.63 to -1.87).
There was no significant difference in readmission rates between day hospital patients and controls (n=667, 5 RCTs, RR 0.91 CI 0.72
to 1.15). For patients judged suitable for day hospital care, individual patient data from three trials showed a significant time-treatment
interaction, indicating a more rapid improvement in mental state (n=407, Chi-squared 9.66, p=0.002), but not social functioning (n=
295, Chi-squared 0.006, p=0.941) amongst patients treated in the day hospital. Four of five trials found that day hospital care was
cheaper than inpatient care (with cost reductions ranging from 20.9 to 36.9%).
Authors’ conclusions
Caring for people in acute day hospitals can achieve substantial reductions in the numbers of people needing inpatient care, whilst
improving patient outcome.
P L A I N L A N G U A G E S U M M A R Y
Day hospital versus admission for acute psychiatric disorders
Day hospitals are a less restrictive alternative to inpatient admission for people who are acutely and severely mentally ill. This review
compares acute day hospital care to inpatient care. It was found that at least one in five patients currently admitted to inpatient care
could feasibly be cared for in an acute day hospital. The psychiatric symptoms of inpatients deemed suitable for acute day care appeared
to improve more quickly than if the person had been cared for as an inpatient. Day hospital care was also less expensive than inpatient
care.
B A C K G R O U N D
Despite the growth of community care, many people with acute
psychiatric disorders continue to be treated as inpatients (DoH
1996). This is an expensive way of caring for such patients (Audit
Comm1994) and surveys suggest that it is oftenunnecessary (Beck
1997). It has been proposed that many of those currently treated
as inpatients could instead be treated in day hospitals (Pang 1985).
The psychiatric day hospital has been defined as a unit that pro-
vides “diagnostic and treatment services for acutely ill patients
who would otherwise be treated on traditional psychiatric inpa-
tient units” (Rosie 1987). The acute psychiatric day hospital is to
be distinguished from other types of “partial hospitalisation” or
“day care” such as transitional care for patients leaving hospital,
more intensive alternatives to outpatient care (day treatment pro-
grammes), and support of long term patients living in the com-
munity (day care centres) (Rosie 1987, Hoge 1992).
Psychiatric day hospitals were first described in the Soviet Union
in the 1930s where they arose as a result of bed shortages (Volovik
1986). The firstNorth American day hospital was opened inMon-
treal, Quebec in 1946, also in an attempt to reduce the demand for
inpatient beds (Cameron 1947). In the USA day hospitals became
a popular way of treating people in the 1960s following the 1963
Community Mental Health Center Construction Act, which set
in law the need to establish partial hospitalisation programmes
(Pang 1985). Similar developments encouraged the growth of day
hospitals in the UK in the 1960s, and in theNetherlands andWest
Germany in the 1970s (Schene 1986). In the 1980s, however,
research commissioned by the American Psychiatric Association
showed widespread closure of partial hospitalisation programmes
and a low rate of growth in the numbers of patients served by such
programmes (Krizay 1989).
A number of factors appear to have contributed to the decline.
Firstly, there was a growing awareness of the limited evidence for
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the effectiveness and cost effectiveness of day hospitals (Vaughn
1983, Creed 1989). Secondly, day hospitals faced competition
from more radical “non-institutional” alternatives, such as as-
sertive community treatment (Hoge 1992). Thirdly, confusion
over the role of day hospitals, led to some becoming expensive day
centres, as they were overwhelmed by inappropriately placed long-
term patients (Pryce 1982). Despite these problems, remorseless
pressure on inpatient facilities has led to continued interest in psy-
chiatric day hospitals and has inspired the development of new-
style day hospitals augmented by outreach services, crisis beds,
and extended hours programmes (Schene 1988, Sledge-US-1996,
Creed-UK-1996).
Despite fifty years of research, opinion remains divided on the cost
effectiveness of day hospital treatment. Proponents have claimed
that it can provide more cost-effective care by: promoting quicker
recovery (Cameron 1947), improving social functioning (Schene
1986, Greene 1981), reducing family burden (Pang 1985), short-
ening the duration of hospital care (Parker 1990), and reducing
relapse rates (Moscowitz 1980). Critics, however, highlight the
high rates of patients lost to follow up in day hospital studies
(Wilkinson 1984), and question whether day hospital treatment
might actually ’institutionalise’ patients by encouraging them to
attend for overlong periods of time (Hoge 1992).
O B J E C T I V E S
The objective was to assess the effects of admission to a psychiatric
day hospital versus admission to inpatient care for people with
acute psychiatric disorders.
The main hypothesis was that admission to a day hospital would
reduce the extent of hospital care and total costs of care, without
any deterioration in follow up rates or clinical and social function-
ing.
In addition the review attempted to determine; i. for what propor-
tion of acutely ill patients day hospital treatment was feasible, ii.
whether patients recover at the same rate in day hospital treatment
(in terms of symptoms and social functioning), and iii. how far
clinical and social recovery was affected by personal characteristics
such as diagnosis, sex, and age.
The review was not concerned with the other modes of ’partial
hospitalisation’ listed above i.e. day treatment programmes and
day centres, which have been reviewed elsewhere (Marshall 2001).
The use of partial hospitalisation as a form of transitional care is
reviewed elsewhere on the Cochrane Library (Johnstone 2001).
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials.
Types of participants
People with acute psychiatric disorders (all diagnoses) who would
have been admitted to inpatient care, if acute day hospital care
had not been available.
Studies were not eligible if they were restricted to, or included a
majority of, patients who were aged under 18 or over 65, or who
had a primary diagnosis of substance abuse and/or organic brain
disorder.
Types of interventions
1. Acute psychiatric day hospitals; units that provided diagnostic
and treatment services for acutely ill patients who would otherwise
be treated on traditional psychiatric inpatient units.
2. Standard inpatient care.
Types of outcome measures
Primary outcomes
1. Lost to follow up
Secondary outcomes
1. Feasibility and engagement
1.1 Unsuitable for day patient care
2. Extent of hospital care
2.1 Duration of initial admission
2.2 Days in inpatient care
2.3 Days in day patient care
2.4 Days in inpatient or day patient care
2.5 Re-admitted to inpatient or day patient care after discharge
3. Clinical and Social outcomes
3.1 Mental state
3.2 Social functioning
3.3 Burden on carers
3.4 Deaths
3.5 Employed at end of study
3.6 Satisfaction with care
3.7 Quality of life
4. Costs of care
4.1 Cost of index admission
4.2Cost of hospital care (meanmonthly - comprising cost of index
admission plus cost of subsequent admissions)
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4.3 Cost of psychiatric care (mean monthly - comprising cost of
hospital care plus cost of all ambulatory psychiatric care)
4.4 Cost of all care (meanmonthly - comprising cost of psychiatric
care plus costs of other medical/social care, but excluding wages,
costs to relatives, and transfer payments)
Search methods for identification of studies
Electronic searches
The search began by deriving a list of search terms from reading
overviews of the field and consulting experts in day hospital care.
The reference databases listed below were searched using Ovid
Biomed.
1. CINAHL (January 1982 - December 2000) was searched us-
ing the Cochrane Schizophrenia Group’s search strategy for ran-
domised controlled trials combined with the phrase: [((DAY adj2
HOSP*) or (DAY adj2 CARE) or (DAY adj2 TREATMENT*)
or (DAY adj2 CENT*) or (DAY adj2 UNIT*) or (PARTIAL adj2
HOSP*) or (DISPENSARY)) ANDMENTAL DISORDERS].
2. The Cochrane Library (Issue 4, 2000) was searched using the
phrases: [((DAY near HOSP*) or (DAY near CARE) or (DAY near
TREATMENT*) or (DAY near CENT*) or (DAY near UNIT*)
or (PARTIALnearHOSP*) or (DISPENSARY)) ANDMENTAL
DISORDERS exploded].
3. EMBASE (January 1980 - December 2000) was searched us-
ing the Cochrane Schizophrenia Group’s search strategy for ran-
domised controlled trials combined with the phrase: [((DAY adj2
HOSP*) or (DAY adj2 CARE) or (DAY adj2 TREATMENT*)
or (DAY adj2 CENT*) or (DAY adj2 UNIT*) or (PARTIAL adj2
HOSP*) or (DISPENSARY)) ANDMENTAL DISORDERS].
4. MEDLINE (January 1966 - December 2000) was searched us-
ing the Cochrane Schizophrenia Group’s search strategy for ran-
domised controlled trials combined with the phrase: [((DAY adj2
HOSP*) or (DAY adj2 CARE) or (DAY adj2 TREATMENT*)
or (DAY adj2 CENT*) or (DAY adj2 UNIT*) or (PARTIAL adj2
HOSP*) or (DISPENSARY)) ANDMENTALDISORDERS/All
subheadings exploded].
5. PsycLIT (January 1967 - December 2000) was searched us-
ing the Cochrane Schizophrenia Group’s search strategy for ran-
domised controlled trials combined with the phrase: [((DAY adj2
HOSP*) or (DAY adj2 CARE) or (DAY adj2 TREATMENT*)
or (DAY adj2 CENT*) or (DAY adj2 UNIT*) or (PARTIAL adj2
HOSP*) or (DISPENSARY)) ANDMENTAL DISORDERS].
Searching other resources
1. Reference searching
The sensitivity of the search strategy was examined by comparing
the results of the search with the reference lists of the identified
reviews and trials, but no new trials were identified.
2. Personal contact
Researchers in the field were approached to identify unpublished
studies.
Data collection and analysis
1. Selection of trials
Two reviewers independently inspected abstracts of the reports
identified by the search (MM and AA). Potentially relevant ab-
stracts were identified (i.e. those in which a group of day hospi-
tal patients meeting the patient inclusion criteria were compared
against a control group) and full papers ordered. A reliability study
found complete agreement on which trials met inclusion criteria.
2. Assessment of quality
Each reviewer allocated the included trials to one of three cat-
egories of allocation concealment, as described in the Cochrane
Collaboration Handbook (Clarke 2000). Disagreements were re-
solved by discussion, or failing this, by seeking further information
from the trialists. For the purposes of assessing feasibility of day
hospital treatment, data was used from trials in all categories of
allocation concealment. However, for the purposes of evaluating
outcome, only data from trials in Category A or B were included
in the review (i.e. randomised trials where method of allocation
concealment was either adequate or unclear). Trials were also rated
on degree of blindness. Blinding of patients and treating clinicians
is not possible in a trial of day hospital treatment, but trials were
rated on independence and blinding of evaluators (non-indepen-
dent evaluators being defined as those also involved in the treat-
ment of trial patients).
3. Data collection
Where further clarification was needed, the authors of trials were
contacted to provide missing data. Individual patient data were
sought for all patients randomised in eligible trials (published or
unpublished). The individual patient data requested were; date of
birth or age, sex, diagnosis, randomisation status, social function-
ing at various time points, mental state at various time points, sat-
isfaction with care, days in hospital, days in day hospital, time to
discharge, number readmitted, deaths, employed at end of study
and costs of care. All individual patient data received were veri-
fied against the original trial reports to ensure both the accuracy
of the meta-analysis database and the quality of randomisation
and follow-up. Any queries were resolved by contacting the tri-
alists. The responsible trial investigator or statistician verified the
final database entries. For trials where individual patient data were
not available, categorical and continuous data were extracted sep-
arately from trial reports by two reviewers and crosschecked (by
MM and either AA or RC).
4. Feasibility of day hospital treatment.
The feasibility of day hospital treatmentwas defined as the percent-
age reduction in acute inpatient admissions that could be achieved
by diverting patients to an acute day hospital. Feasibility was es-
timated by a modification of the method suggested by Kluiter
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(Wiersma-NL-1989), the general formula being: 100 x number
engaging in day hospital treatment / (number assessed for eligi-
bility x R), where R is the randomisation ratio for the trial (de-
fined as number randomised to day hospital divided by number
of patients randomised). However, estimates of feasibility are pro-
foundly affected by judgements about what is ’engagement’ in day
hospital treatment and how many patients have been assessed for
eligibility. It was therefore decided to perform a sensitivity analysis
to give a best and worst estimate of feasibility for each included
trial.
The best estimate was based on defining: i. engagement in day
hospital as the number randomised to day hospital treatment, and
ii. assessed for eligibility as the number remaining after exclusions
for administrative reasons. Patients excluded for administrative
reasons were defined as those who were too well to be randomised
to day care, left before they could be assessed or lived outside the
study catchment area. The worst estimate of feasibility was based
on defining: i. engagement in day hospital as the number ran-
domised to day hospital treatment (those admitted as inpatients
in the first four weeks + the number of day patients who did not
turn up for day hospital treatment) and ii. assessed for eligibility
as the number presenting for admission before any administrative
exclusions were made. A weighted average was derived for the best
and worst estimates of feasibility derived in this way. However, for
a minority of trials (referred to as ’Type 2’ trials, see Description of
Studies below) this formula for calculating feasibility could not be
applied because all patients were admitted to inpatient care before
randomisation to continuing inpatient care or day hospital care.
For these trials a single estimate of feasibility was calculated, based
on those patients randomised to day hospital care who experienced
only a brief episode of inpatient care before transfer to a day hospi-
tal. Number lost to follow up was estimated by taking the number
who were not re-interviewed at the final follow-up assessment. It
was assumed that clients lost to follow up also dropped out of care.
5. Data synthesis
5.1 Use of individual patient data
Individual patient data were used in two ways. Firstly, these data
were used to ’fill gaps’ arising from incomplete reporting of the in-
formation required by the reviewers in the available publications.
Data used in this way weremainly binary and were combined with
binary data extracted from published reports. Secondly, individual
data were combined across trials and subjected to a fresh statistical
analysis (see 5.4.6 below). Data used in this way were either con-
tinuous or were binary co-variates, and were not combined with
data extracted from published reports.
5.2 Incomplete data
Datawere excluded if they could not be analysed on an intention to
treat basis; for example if peoplewere excludedpost-randomisation
for reasons other than loss to follow up. Data were also excluded
from studies where more than 50% of people were lost to follow
up (except for the outcome of ’lost to follow up’). Continuous data
available only from trial reportswere noted in the text, butwere not
included in the meta-analysis (this was not an a priori exclusion,
there were just no instances where these data were presented in a
usable form).
5.3 Binary data
For binary outcomes a standard estimation of the risk ratio (RR)
and its 95% confidence interval (CI) was calculated. If the relative
risk was significant, the number needed to treat statistic (NNT)
was also calculated, using StatsDirect Statistical Software (Buchan
2001). If heterogeneity was found (see section 6) a random effects
model was used.
5.4 Continuous data
5.4.1 Summary statistic
For continuous outcomes a weightedmean difference (WMD) be-
tween groups was estimated. Continuous data derived from indi-
vidual patient data were presented on RevMan even when skewed,
however in such cases the WMDs reported in the text are accom-
panied by the results of a non-parametric analysis of the data.
Continuous data presented without use of summary statistics (i.e.
mean, SD/SE or non-parametric equivalent) were not considered
good evidence, though the existence of such data was noted in the
text.
5.4.2 Valid scales
Unpublished scales are known to be subject to bias in trials of
treatments for schizophrenia (Marshall 2000). Therefore contin-
uous data from rating scales were included only if the measuring
instrument had been described in a peer-reviewed journal and the
instrument was either a self-report or completed by an indepen-
dent evaluator or relative.
5.4.3 Conversion to a common metric
To facilitate comparisons between trials, variables (such as days
in hospital) that could be reported in different metrics were con-
verted to a common metric (such as mean days in hospital per
month). Time spent in the day hospital was adjusted so that ’days
in day hospital’ represented the actual number of attendances at
the day hospital (excludingmissed days), rather than the total time
for which the patient was a day hospital patient (except in the case
of duration of initial admission). Creed-UK-1990 did not distin-
guish between duration of care and actual number of attendances,
so actual number of attendances was estimated using the same
ratio of duration:actual attendances reported in Creed-UK-1996
(which took place in the same day hospital using the same hospital
control).
5.4.4 Skewed data
Data concerning use of hospital care were skewed, but were
nonetheless presented on RevMan to facilitate comparison be-
tween trials, however, the results of any parametric analyses on
these data were cross-checked using the non-parametric Mann-
Whitney U statistic.
5.4.5 Standardisation of data collected by different scales
For both mental state and social function, there was no common
outcome measure across the included studies. Outcomes for men-
tal state and social function for each study providing individual
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patient data were standardised to give variables with zero mean
and standard deviation of one so that the data sets could be pooled
into a single analysis,
5.4.6 Analysis of individual patient data
Since a difference in the effect of treatment would manifest itself
in a more rapid decline in one treatment group than the other, a
statistical analysis was performed in which lines were fitted to each
subject using a multilevel regression model. The average effect of
treatment over time was expressed as a mean line for each treat-
ment. The slope of themean line for each treatment was compared
and a treatment effect was measured by the time-treatment group
interaction. Random intercepts were considered to allow for in-
dividual variation between patients within treatment groups. An
initial analysis was carried out to assess whether a random slope ef-
fect term needed to be included in the models. To assess the effect
of treatment, a full model with a time-intervention group inter-
action was compared with a reduced model excluding this term.
All analysis was performed using MLwiN (Rabash 1998), which
provides a system for the specification and analysis of a range of
multilevel models with estimation using iterative generalised least
squares. Three covariates common to the included trials (age, di-
agnosis and sex) were included in the analysis.
5.4.7 Economic data
Individual patient data on economic variables were not combined
across trials because there is no agreed method for overcoming
the problems caused by differences in costing methodology be-
tween trials and between countries. Instead, these data were pre-
sented adjusted to a common format (see types of outcome mea-
sure above) in the currencies used in the original trials. Percent-
age differences in costs between treatment and control condi-
tions were then calculated and, where possible, costs of treatment
and control care were compared using non-parametric tests. For
Creed-UK-1990 costs of hospital care were calculated using indi-
vidual patient data, working on the assumption that the relative
costs of day hospital and inpatient care were similar to those re-
ported in Creed-UK-1996 (both trials took place in the same day
hospital with the same general hospital control).
6. Test for heterogeneity
A Chi-square test was used, as well as visual inspection of graphs,
to investigate the possibility of heterogeneity. A significance level
less than 0.10 was interpreted as evidence of heterogeneity. If het-
erogeneity was found the data were re-analysed using a random
effects model. If this made a substantial difference, the studies re-
sponsible for the heterogeneity were presented separately from the
main body of homogeneous trials and the reasons for heterogene-
ity were investigated.
7. Addressing publication bias
There were insufficient data to address the question of publication
bias. Had sufficient data been available, they would have been
entered into a funnel graph (trial effect against trial size) in an
attempt to investigate the likelihood of overt publication bias (
Egger 1997).
8. Sensitivity analyses
Sensitivity analyses were not performed due to lack of adequate
data (see results below).Withmore data, sensitivity analyses would
have been used to examine the effect of excluding studies with (a)
high attrition rates (>20%), (b) non-independent or non-blind
raters and (c) allocation concealment in category B.
9. General
Where possible, reviewers entered data so that the area to the left
of the line of no effect indicated a favourable outcome for the
intervention (i.e. acute day hospital care).
10. Modifications to original protocol.
10.1 After writing the initial protocol it became obvious that it
would be difficult to synthesis summary data from the included
trials because of the range and complexity of the outcome variables
that had been used. For example, one key outcome, use of hospital
care, had been reported in terms of days in inpatient care, duration
of day patient care, adjusted duration of day care (discounting
weekends and days off ), duration of index admission, nights out
of hospital, actual attendances at day care, readmission to day care,
readmission to inpatient care and so on. The result was that whilst
most acute day hospital trials reported similar outcomes, these
outcomes were rarely in the same format and hence could not
be combined across trials. The picture was further complicated
because many of the outcome variables were skewed, and tended
to be presented in forms (such asmedians) which cannot be readily
synthesised in a meta analysis. It was therefore considered essential
to obtain individual patient data from included trials so that the
relevant outcomes could be presented in a common format.
10.2 The original protocol proposed to look at a number of dif-
ferent ways of using day hospitals, in addition to using them as an
alternative to admission. This was too large a project to be con-
tained in a single review, so alternative uses of day hospitals are
covered in a separate review (Marshall 2001).
10.3 The original protocol did not propose to look at feasibility of
day hospital treatment. On reading the original papers and reviews
it became clear that this was an important question that should be
addressed by the review. Feasibility was therefore added to the list
of outcomes.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
For substantive descriptions of studies please see Included and
Excluded studies tables.
1. Excluded studies
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Sixty-four studies were excluded; 43 were not randomised studies
and 21 were randomised controlled trials. The non-randomised
studies consisted of; two surveys (without comparison groups),
11 surveys with comparison groups, two uncontrolled follow-up
studies, four ’before and after’ comparisons, eight case-control
or retrospective cohort studies and 16 quasi-experimental designs
(i.e. comparative trials without randomisation). The excluded ran-
domised controlled trials consisted of; one trial of admission to
hospital versus outpatient care, eight trials of day hospital versus
outpatient care, five trials of short versus long hospitalisation (in
which day hospital care was used to reduce the duration of ad-
mission), four trials of enhanced day hospital care versus stan-
dard day hospital care (involving enhancement by cognitive ther-
apy, problem solving, group therapy and self-control therapy re-
spectively), two trials of acute day hospital care versus admis-
sion (Creed-Blackburn, Platt-London) and one trial that could
not be classified (Guy-Baltimore). Creed-Blackburn was excluded
because the trialists concluded that the randomisation procedure
was compromised. Platt-London was excluded because the trial
was abandoned following recruitment difficulties. Guy-Baltimore
could not be classified as the day hospital in question functioned
simultaneously as a day care centre, a day treatment programme
and a transitional day hospital.
2. Awaiting assessment
There were seven studies awaiting assessment. Three await trans-
lation and four have not yet been obtained.
3. Ongoing studies
One ongoing randomised controlled trial was identified of acute
day hospital care versus admission, but no further data were avail-
able at the time of going to press (Priebe-UK-2000).
4. Included studies
Nine trials (involving 1568 randomised patients and 2268 who
were assessed for suitability of day hospital treatment) were in-
cluded in the review (Creed-UK-1990, Creed-UK-1996, Dick-
UK-1985, Herz-US-1971, Kris-US-1965, Schene-NL-1993,
Sledge-US-1996, Wiersma-NL-1989, Zwerling-US-1964).
4.1 Pre-randomisation exclusions vs everyone randomised
Included trials were found to be of two types. Type 1 trials ex-
cluded, before randomisation, any patients who were considered
ineligible for day hospital treatment (for example too violent or
under compulsion). The Type 1 trials were: Creed-UK-1990,
Creed-UK-1996,Dick-UK-1985,Herz-US-1971,Kris-US-1965,
Schene-NL-1993, Sledge-US-1996. Type 2 trials randomised all
patients presenting for admission regardless of suitability, but ad-
mitted to the inpatient ward any people allocated to day hospital
who were too unwell for immediate day hospital treatment. The
Type 2 trials were: Wiersma-NL-1989 and Zwerling-US-1964.
The methodological differences between Type 1 and Type 2 trials
meant that they could not be analysed in the same comparison.
4.2 Duration
The follow-up periods of the Type 1 trials were: 2 months (Kris-
US-1965); 6 months (Schene-NL-1993); 10 months (Sledge-US-
1996); 12 months (Creed-UK-1990, Creed-UK-1996, Dick-UK-
1985); and 24 months (Herz-US-1971). In one trial (Sledge-US-
1996) the follow-up period began on discharge from inpatient/
day patient care, whereas in the others it began on the day of
randomisation. Both Type 2 trials had follow-up periods of two
years.
4.3 Participants and setting
4.3.1 Type 1 trials
All Type 1 trials recruited from a population who would other-
wise have been admitted to a general adult psychiatric ward. Two
trials took place in the same day hospital in an inner city area of
Manchester, UK (Creed-UK-1990, Creed-UK-1996). In the ear-
lier trial, eligible patients were voluntary patients who were not
too ill for day care, and who had no social factors that made day
care impractical (such as being of no fixed abode). In addition to
these criteria, the later trial excluded patients with organic brain
disease or mania. Dick-UK-1985 took place in an acute day hos-
pital in Dundee, Scotland. Patients were excluded if day hospi-
tal treatment was judged impractical or they were considered too
ill or suicidal. Herz-US-1971 took place in an acute day hospital
in New York State, USA. Patients were excluded if day care was
judged impractical or if they were considered too ill or too well
for day care. Kris-US-1965 took place in an acute day hospital in
New York, USA. Patients were eligible if they had had a previous
admission for a psychotic disorder. Schene-NL-1993 took place
in an acute day hospital at the University of Utrecht, Netherlands.
Patients were excluded if there were contraindications to day hos-
pital treatment (not specified) or they had organic brain disease
or a primary diagnosis of substance abuse or mental retardation.
Sledge-US-1996 took place at a community mental health centre
day hospital in New Haven, Connecticut, USA. The day hospital
was closely linked to a crisis residence run by a non-profit organi-
sation. Patients were excluded if they were; involuntary, not living
locally, too ill for day patient treatment, intoxicated, or physically
unwell.
4.3.2 Type 2 trials
Wiersma-NL-1989 took place in a day hospital operated by the
Regional Institute for Ambulatory Mental Health Care in Gronin-
gen, Netherlands. All patients presenting for inpatient care were
included in the trial except for forensic patients on court orders
and patients with dementia. No prior assessment was made of
suitability for day hospital treatment. Patients randomised to day
hospital treatment who were too unwell for immediate transfer
were treated as inpatients but transferred to day hospital care as
soon as feasible. Zwerling-US-1964 took place in a day hospital
in New York, USA. All patients presenting for inpatient care were
included in the trial.
4.4 Study size
No study reported a pre-trial power calculation.
4.4.1 Type 1 trials
The trials in descending order of size were: Schene-NL-1993
(222), Sledge-US-1996 (197); Creed-UK-1996 (187); Kris-US-
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1965 (141); Creed-UK-1990 (102); Dick-UK-1985 (91) and
Herz-US-1971 (90).
4.4.2 Type 2 trials
The trials in descending order of size were: Zwerling-US-1964
(378) and Wiersma-NL-1989 (160).
4.5 Interventions
4.5.1 Type 1 trials
In Creed-UK-1990 eight nurses and three occupational therapists
staffed the day hospital with sessional input from three consul-
tant psychiatrists. In Creed-UK-1996 the day hospital had simi-
lar staffing levels to Creed-UK-1990, but there was additional in-
put from a community psychiatric nurse (who could visit patients
who failed to turn up for treatment) and an out of hours on-call
service for day patients. In Dick-UK-1985 the day hospital was
staffed by two trained staff and an occupational therapist and had
a staff:patient ratio of 1:12.5. The day hospital offered individual
counselling, groups, activities and medication. In Herz-US-1971
the day hospital offered group-oriented psychotherapy, staffing
levels were not reported. In Kris-US-1965 the day hospital of-
fered milieu and group therapy, staffing levels were not reported.
In Schene-NL-1993 the day hospital offered psychosocial therapy
and had a staff: patient ratio of 1:12.5. In Sledge-US-1996 the day
hospital was a 20 patient facility staffed by doctors, nurses, social
workers and other therapists. Treatment emphasised group work,
control of symptoms and improvement in daily living skills. The
day hospital was linked to a crisis residence, which was a three-
bedroom apartment supported by a crisis respite unit.
4.5.2 Type 2 trials
In Wiersma-NL-1989 the day hospital was supported by inte-
grated ambulatory and domiciliary care and by a back up bed on
the inpatient ward. A 24-hour telephone help-line was available
to all day hospital patients. The day hospital offered a multi-dis-
ciplinary treatment programme, but staffing levels were not re-
ported. In Zwerling-US-1964 the day hospital offered group-ori-
ented activities and family therapy for up to 30 patients. Staffing
consisted of four full time nurses, four nurse’s aides, a clinical psy-
chologist, a social worker and dedicated time from senior and ju-
nior psychiatrists.
4.6 Outcomes
4.6.1 Type 1 trials
Schene-NL-1993 was not carried out on an intention to treat
basis (see methodological quality below) and so provided data on
feasibility only. Individual patient data was not sought for this trial
as it could not be analysed on an intention to treat basis.
4.6.1.1 Individual patient data
Individual patient data were sought for six of the seven Type 1
trials (excluding Schene-NL-1993) and obtained for three (Creed-
UK-1990, Creed-UK-1996, Sledge-US-1996). These individual
patient data covered 486 patients. Of the three remaining trials,
contact with the trialists confirmed that individual patient data
were no longer available for Herz-US-1971 or Dick-UK-1985.
The trialists for Kris-US-1965 could not be located.
4.6.1.2 Missing Outcomes
After taking individual patient data into account, Type 1 trials
provided useable data on all the outcomes defined under ’Types
of Outcome Measure’ above, except quality of life.
4.6.1.3 Continuous outcomes
Details of the scales that supplied useable data for this review are
given below. Reasons for exclusion of data from other scales are
given in the Outcomes column of the ’Characteristics of Included
Studies Table’.
a. Mental State
i. Present State Examination (Wing 1972) in Creed-UK-1990.
This is a clinician-rated scale measuring mental status. One hun-
dred and forty symptom items are rated and combined to give var-
ious syndrome and sub-syndrome scores. Higher scores indicate
increased severity of psychiatric symptoms.
ii. Comprehensive Psychopathology Rating Scale (Asberg 1978)
in Creed-UK-1996. A four-point scale is used to rate 40 items,
and 25 items are rated by observation using the same scale. Global
rating of the illness is an additional item. Higher scores indicate
increased severity of psychiatric symptoms.
iii. Brief Psychopathology Rating Scale (BPRS, Overall 1962) in
Sledge-US-1996. A brief rating scale used to assess the severity of
a range of psychiatric symptoms, including psychotic symptoms.
The scale has 16 items, and each item can be defined on a seven-
point scale varying from ’not present’ (0) to ’extremely severe’ (6).
iv. Clinical Interview Schedule (Goldberg 1972) in Dick-UK-
1985. Scoring method is unclear in this particular trial, “twice
the sum of the mental state ratings was added to the sum of the
symptom ratings to give an overall severity score”. Higher scores
indicate increased severity of psychiatric symptoms.
b. Social Functioning
i. Social Behaviour Assessment Schedule (Platt 1981) in Creed-
UK-1990 & Creed-UK-1996. This scale yields scores in three
areas: social role performance (used here), abnormal behaviours
(not used) and burden on relatives (used below). Higher scores
indicate greater social dysfunction.
ii. Social Adjustment Schedule (SAS, Weissman 1981) in Sledge-
US-1996.Measures social functioning in a number of life domains
(work, social, extended family, marital, parental, family unit, and
economic adequacy) on a scale of 1-7. Lower scores indicate poorer
functioning.
Burden on Relatives
iii. Social Behaviour Assessment Schedule (burden sub-scale, Platt
1981) in Creed-UK-1990.
4.6.2 Type 2 trials
Zwerling-US-1964 was not carried out on an intention to treat
basis (see methodological quality below) and so provided data on
feasibility only. Individual patient data was not sought for this trial
as it could not be analysed on an intention to treat basis.
4.6.2.1 Missing Outcomes
Taking individual patient data into account, Type 2 trials provided
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useable data on all outcome variables except duration of index
admission, burden on carers and quality of life.
4.6.2.2 Individual patient data
Individual patient data were sought for one of the two Type 2 trials
(excluding Zwerling-US-1964) and were obtained (Wiersma-NL-
1989, n=160).
4.6.2.3 Continuous outcomes
a. Mental State
Present State Examination in Wiersma-NL-1989 (see 4.5.1.3
above).
b. Social Functioning
Groningen Social Disabilities Schedule (Wiersma 1988) in
Wiersma-NL-1989. Rated on a scale of 0 to 4 with higher scores
indicating greater social disability.
Risk of bias in included studies
1. Intention to treat analysis
Two trials (one Type 1 and one Type 2) were not carried out
on an intention to treat basis. Schene-NL-1993 ceased to collect
data after randomisation on any patients who had an admission
of less than 28 days or were transferred to a closed ward for more
than 28 days. Zwerling-US-1964 failed to report data on patients
with organic brain disease (who were excluded from day hospital
care after randomisation). This meant that data from these trials
could not be analysed on an intention to treat basis, so all data
were excluded, other than data on the proportion suitable for day
hospital treatment.
2. Randomisation
Allocation concealment was adequate in five of nine trials, three of
which used randomisation by sealed envelope (Creed-UK-1990,
Creed-UK-1996, Wiersma-NL-1989) and two of which used a
centralised randomisation method (Sledge-US-1996, Zwerling-
US-1964). In Herz-US-1971 and Kris-US-1965 the method of
allocation concealment was unclear, and in Schene-NL-1993 it
was inadequate in that 14 patients were withdrawn after allocation
because of “incorrect randomisation”. All trials providing individ-
ual patient data had adequate allocation concealment. Data from
trials with inadequate or unclear allocation concealment may be
subject to bias (Schulz 1995), however Schene-NL-1993 provided
feasibility data only, whilst Kris-US-1965 contributed limited data
to one outcome only (employment). Herz-US-1971 contributed
more substantial data to the review, but exclusion of this data does
not substantially alter the main findings.
3. Blinding to interventions and outcomes
Blinding of participants and of clinical staff is not possible in trials
of day hospital care, although it is possible to use evaluatorswho are
independent of the treating clinicians andblind to group allocation
(though maintaining blinding could be difficult). None of the
nine trials used evaluators who were blind to group allocation,
but seven used evaluators who were independent. In Kris-US-
1965 and Schene-NL-1993 it was unclear if the evaluators were
independent. Exclusion of the data from these two trials does not
substantially alter the findings of the review (see randomisation
above).
4. Follow-up
Follow-up rates were as follows; Creed-UK-1990 69% at 12
months, Creed-UK-1996 76.5% at 12 months, Dick-UK-1985
71.4% at 12 months, Herz-US-1971 81.2% at 24 months, Kris-
US-1965 not reported, Schene-NL-1993 not clear due to post-
randomisation exclusions, Sledge-US-1996 71.6% at 10 months,
Wiersma-NL-1989 59% at 24 months, Zwerling-US-1964 92%
at 24 months. The reasons why patients were lost to follow-up
were clearly reported in Creed-UK-1990 and Herz-US-1971.
5. Individual patient data
No substantial discrepancies were noted between the summary
data in published reports and the summary data calculated from
individual patient data, thus indicating that the correct data sets
had been obtained.
6. Changes in the nature of day hospital treatment.
It was noted that in the three of the more recent trials, day hospi-
tal care was augmented by sleep-over facilities (Sledge-US-1996)
or outreach services (Creed-UK-1996, Wiersma-NL-1989). This
suggests that day hospital practice may be evolving over time and
so it is recommended that trials are viewed sorted by year in
MetaView.
Effects of interventions
1. The search
The electronic searches resulted in the following number of “hits”:
Cinahl 43, The Cochrane Library 627, Embase 592, Medline
1060 and PsycLIT 91.
For methodological reasons it was necessary to carry out separate
comparisons for Type 1 and Type 2 trials (see Description of Stud-
ies 4.1), however, since the interventions are similar, the findings
of the two comparisons have been reported together for each out-
come.
2. COMPARISON: DAY PATIENT vs INPATIENT CARE
2.1 Feasibility and engagement
2.1.1 Proportion of patients suitable for day patient care
The feasibility of day treatment was defined as the percentage
reduction in acute inpatient admissions that could be achieved by
diverting patients to an acute day hospital (see ’Methods of the
Review’ 4. above). Table 1 summarises the data on the proportion
of patients suitable for day hospital treatment. For Type 1 trials,
the combined optimistic estimate of feasibility was 37.5% (n=
1768, CI 35.2 to 39.8), whilst the combined pessimistic estimate
was 23.2% (n=2268, CI 21.2 to 25.2). For Type 2 trials (Table
2) the estimate of feasibility ranged from 18.4% (from Wiersma-
NL-1989 which reported the number of patients averaging six or
more nights per week away from hospital in the first 15 weeks
of the trial) to 39.1% (based on Zwerling-US-1964, a trial which
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reported the number of patients treated entirely in the day hospital
without readmission).
2.1.2 Number lost to follow up
Five Type 1 trials (Creed-UK-1990, Creed-UK-1996, Dick-UK-
1985,Herz-US-1971, Sledge-US-1996) provided data on number
lost to follow-up, showing no difference between day hospital and
control groups (n=667, RR 0.97 CI 0.74 to 1.27). These data,
however, showed evidence of heterogeneity (p=0.07) and analysis
by year of publication suggested a time dependent effect, with
earlier trials having a higher dropout rate in the day hospital group
and later trials having either a similar or a lower drop out rate
in the day hospital group. One Type 2 trial (Wiersma-NL-1989)
provided data on number lost to follow-up, showing a significant
difference in favour of the day hospital group (n=160, RR 0.69
CI 0.48 to 0.99, NNT 6).
3. Extent of hospital care
3.1 Duration of initial admission
Three Type 1 trials (Creed-UK-1990, Creed-UK-1996, Sledge-
US-1996) provided individual patient data that permitted calcu-
lation of the duration of index admission (defined as time from
first admission to discharge to outpatient care). These data showed
that patients randomised to day hospital care had a significantly
longer index admission (n=465, weighted mean difference 10.9
days CI 1.09 to 20.7, Mann Whitney U, Z= -3.255, p=0.001).
There was, however, significant heterogeneity (chi square = 20.17,
d.f.2, p<0.01). This heterogeneity was attributable to differences
between the two UK trials (where day patient was significantly
longer than in patient stay), and the US trial (where day patient
was shorter than inpatient stay). TwoType 1 trials (Herz-US-1971,
Dick-UK-1985) also provided data on duration of index admis-
sion, but in a form that could not be included in the meta-analysis
(Table 3). There was no data on duration of index admission from
Type 2 trials.
3.2 Days in inpatient or day patient care
The use of hospital care throughout the study was assessed using
individual patient data from three Type 1 trials (Creed-UK-1990,
Creed-UK-1996, Sledge-US-1996). These data showed no differ-
ence in total number of days in hospital between day hospital pa-
tients and controls (n=465, WMD -0.38 days/month CI -1.32 to
0.55, Mann-Whitney U, Z=-0.971, p=0.332). However, further
analyses of these data showed that, compared to controls, patients
randomised to day hospital care spent significantly more days in
day hospital care (n=265, WMD 2.34 days/month CI 1.97 to
2.70, Mann-Whitney U, Z=-14.33, P<0.001) and significantly
fewer days in inpatient care (n=265, WMD -2.75 days/month CI
-3.63 to -1.87, Mann-Whitney U, Z=-11.89, P<0.001).
Five Type 1 trials provided data on number of patients readmitted
to hospital care (either inpatient or day hospital) after discharge
from the index admission (Creed-UK-1990, Creed-UK-1996,
Dick-UK-1985, Herz-US-1971, Sledge-US-1996). These data
showed no significant difference between day hospital and control
groups (n=667, RR 0.91 CI 0.72 to 1.15).
One Type 2 trial (Wiersma-NL-1989) provided data on the extent
of hospital care, however this was in a format that could not be
easily compared with that from Type1 trials, even though individ-
ual patient data were available. Rather than reporting days in day
hospital or inpatient care, Wiersma-NL-1989 reported “nights in
hospital” (defined as number of nights spent in hospital during
follow up) and “nights out of hospital” (defined for the control
group as nights on leave from inpatient care, and for the day hos-
pital group as number of nights spent at home whilst in day care).
Wiersma-NL-1989 then combined these data to give a total length
of stay in day/inpatient care. Relative to the data from Type 1
trials, the total length of stay as reported by Wiersma-NL-1989,
increases the apparent length of day patient care, because there is
no adjustment for the fact that patients do not attend day hospi-
tal every day of the week. Using this method, Wiersma-NL-1989
found no difference in total number of days in hospital between
day hospital patients and controls (n=160, WMD1.1 days/month
CI -1.57 to 3.77). These data could not be disaggregated into days
in inpatient care and days in day hospital.
4. Clinical and social outcomes
Three Type 1 trials (Creed-UK-1990, Creed-UK-1996, Sledge-
US-1996, total n=486), and one Type 2 trial (Wiersma-NL-1989)
provided individual patient data on mental state and social func-
tioning at various time points. The trials differed in the choice
of questionnaire instruments and time points for follow-up data
collection (Table 4). It was possible to combine the individual pa-
tient data from the three Type 1 trials. Table 5 gives a breakdown
of demographic characteristics of patients from these trials. Forty-
two (8.6 %) people had to be dropped from the statistical mod-
elling of outcome due to incomplete covariate data. These appear
to be evenly distributed between intervention groups (Table 5).
No data were available on quality of life, though one trial had used
an unpublished quality of life scale (Sledge-US-1996).
4.1 Mental state (at various time points)
Due to absence of follow-up mental state data, a further 37
patients (7.6%) from Type 1 trials could not be included in
this analysis. These were divided between as follows: seven from
Creed-UK-1990 (five inpatients and two day patients), seven from
Creed-UK-1996 (five inpatients and two day patients) and 23
from Sledge-US-1996 (16 inpatients and seven day patients).
There was evidence of curvature of the profiles and positive skew-
ness, so a square root transformation was used. The square root
transformed profiles were more linear and the patient and time-
point level residuals less skewed. There was evidence of both a sig-
nificant random intercept (Chi-squared =180.25, p<0.001) and
a significant random slope effect (Chi-squared =25.46, p<0.001)
measured by change in log-likelihood, so both these terms were
included in the statistical modelling. When a full model including
time-treatment interaction was compared with a reduced model
without the interaction, there was evidence of a significant time-
treatment interaction measured by change in log likelihood (Chi-
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squared = 9.66, p=0.002). The difference in slope was -0.007 (CI
-0.011 to -0.002 ) with the negative coefficient representing in-
creased improvement in the day hospital group (Table 5).The in-
tervention group had a significant effect (Chi-squared = 4.58, p=
0.032) indicating a difference in baseline levels for the two groups.
The differencewas 0.144 (CI 0.009 to0.278) representing a higher
baseline for the day hospital group. To ensure that this difference
was not causing the difference in slope, the analysis was repeated
without this term so forcing a common baseline to be modelled.
The overall conclusion did not alter indicating that the differing
baseline values were not causing the significant difference between
slopes. None of the other covariates had a significant effect. Unfor-
tunately it is not possible to estimate the extent of the difference in
improvement rates, as back transformation of square-root trans-
formed data is not easily interpreted. Dick-UK-1985 (which did
not provide individual patient data) also measured mental state
using the Clinical Interview Schedule (Goldberg 1972) at 0.75,
4 and 12 months. No standard deviations were provided, but a
significant difference in favour of day hospital treatment was re-
ported at 0.75 months, but not at the other time points (decrease
in score: 0.75ms DP 13.6 IP 9.6, p<0.001 t test; 4ms DP 16.2
IP 11.6, p=ns; 12ms DP 20 IP 14.1, p=ns). For Type 2 trials,
Wiersma-NL-1989 provided individual patient data on mental
state at 0,12 & 24months, which showed no significant difference
between treatment and control groups.
4.2 Social functioning (at various time points)
Due to absence of follow-up social functioning data, 149 patients
(30.6%) fromType 1 trials could not be included in the analysis of
data. These were divided between the studies as follows; 15 from
Creed-UK-1990 (nine inpatients and six day patients), 83 from
Creed-UK-1996 (43 inpatients and 40 day patients) and 51 from
Sledge-US-1996 (32 inpatients and 19 day patients). There was
evidence of a significant random intercept (Chi-squared = 62.58,
p<0.001) but no significant random slope effect (Chi-squared =
0.80, p=0.67) measured by change in log-likelihood so only the
random intercept was included in the statistical modelling. When
a full model including time-treatment interaction was compared
with a reduced model without the interaction there was no evi-
dence of a time-treatment interaction measured by change in log
likelihood (Chi-squared = 0.006, p=0.941, see Table 6). There
was a significant age (Chi-squared = 7.82, p=0.005) and a signifi-
cant gender effect (Chi-squared = 21.95, p<0.001), with increased
age having a positive effect on improvement and males improving
less. One Type 2 trial (Wiersma-NL-1989) reported data on so-
cial functioning (GroningenSocialDisabilities Schedule,Wiersma
1988) at zero, 12 and 24 months. No significant differences were
found between treatment and control groups on either variable at
any time point.
4.3 Burden on carers (at various time points)
Two trials reported data onburdenon carers (Creed-UK-1990 at 0,
3&12months;Creed-UK-1996 at 0, 0.5, 1, 2, 3, 6&12months),
collected using the SBAS Burden Scale (Platt 1981). However,
data on burden from Creed-UK-1996 at six and 12 months could
not be included as it was available on less than 50% of randomised
patients. The available data showed no difference in carer burden
between day hospital and control groups at two weeks, and one,
two three and 12 months, although there were limited data for all
time points except three months (where weightedmean difference
= -0.59 CI -1.62 to 0.44 i.e. not significant but favouring day
hospital treatment).
4.4 Death (suicide/homicide/all causes)
Although deaths amongst participants were acknowledged in some
Type 1 trials, with one exception (Herz-US-1971 - one death in
control group) these datawere not reported in relation to randomi-
sation group, nor was it possible to derive this information from
individual patient data. One Type 2 trial (Wiersma-NL-1989)
found no difference in death rates between day hospital and con-
trol groups (n=160, RR 0.74, 95% CI 0.17 to 3.18), but confi-
dence intervals were wide.
4.5 Employed at end of study
Two Type 1 trials (Creed-UK-1996 and Kris-US-1965) reported
number unemployed.Kris-US-1965 provided this data onpatients
two months after discharge from day or inpatient care (number
unemployed DP 43/71, IP 57/70, RR 0.74 CI 0.60 to 0.93),
but the duration of the index admission was not specified so the
data were not entered on Metaview. Creed-UK-1996 found no
difference in number unemployed at 12 months (n=179, RR 0.88
CI 0.66 to 1.19). One Type 2 trial (Wiersma-NL-1989) found no
difference in number unemployed at 24 months (n=160, RR 0.95
CI 0.87 to 1.04).
4.6 Satisfaction with care (patients and relatives)
One Type 1 trial (Dick-UK-1985) reported data on number not
satisfied with care, these data showed a significant difference in
favour of day hospital care (n=91, RR 0.46 CI 0.27 to 0.79, NNT
3).
5. Costs of care
Data on costs of care was reported by four Type 1 trials (three pro-
vided individual patient data) and oneType 2 trial (IPDprovided),
see Table 7, Table 8, Table 9, Table 10. The four Type 1 trials
found that day hospital care was cheaper than hospital care (with
eight of eight comparisons across a range of cost indices favouring
day hospital care, six significantly - Table 8). Reductions in costs
ranged from 33.5 to 49.6% for the index admission to 20.9 to
36.9% for the costs of all psychiatric care (including hospital care).
The Type 2 trial found no significant difference between day and
inpatient care in two comparisons, although the trend favoured
inpatient care (see Table 10).
D I S C U S S I O N
1. Quality of design and follow up of included studies
In terms of allocation concealment, the quality of included studies
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was good, particularly of those providing individual patient data.
Whilst no trial used evaluators who were blind to group alloca-
tion, all studies providing individual patient data used indepen-
dent evaluators. Follow-up rates were generally sub-optimal, and
were below 80% in all trials providing individual patient data.
The fact that high attrition rates are common to all recent trials
suggests the problem lies in working with an acutely ill study pop-
ulation, rather than reflecting design limitations in any particular
trial. There was no evidence of a difference in follow-up rates be-
tween treatment and controls in trials providing individual patient
data, so it is unlikely that lower attrition rates would have had
an impact on the findings of this review, however this possibility
cannot be absolutely discounted.
2. COMPARISON: DAY PATIENT vs INPATIENT CARE
2.1 Feasibility, engagement and the extent of hospital care
The evidence for feasibility and extent of hospital use is strong,
being based on large data sets from a number of trials. This review
has found that psychiatric inpatient admissions could be reduced
by about 23% (95% CI 21.2-25.2) if patients were diverted to an
acute day hospital. This substantial reduction could be achieved
without increasing loss to follow up or burden on relatives, al-
though there is insufficient data to judge whether it would have
any effect (positive or negative) on mortality rates. The review
has also shown that whilst patients diverted to acute day hospitals
spend the same number of “days” in “hospital” as inpatients, they
spend significantly more of these days in day hospital care. This
means that the use of acute day hospitals leads to substantial cost
savings because day hospital care is cheaper than inpatient care.
The review has also provided some evidence that patients deemed
suitable for day hospital care benefit clinically, in that they show
more rapid improvement in their mental state and are more sat-
isfied. However, contrary to the suggestions of some experts, day
hospital care does not reduce readmission rates or lead to improve-
ments in social functioning.
2.2 Clinical, social outcomes and burden of care and satisfaction
2.2.1 Mental state
The evidence for clinical effectiveness is reasonable for improve-
ments in mental state but is limited by the fact that the use of a
square root transformation has made it impossible to estimate the
effect size on this variable. The equivocal finding on mental state
from Wiersma-NL-1989 does not contradict the positive finding
from Type 1 trials because (i) the increased rate of improvement
appears to occur before one year (in Wiersma-NL-1989 the first
follow up is at one year), and (ii) Wiersma-NL-1989 was a Type
2 trial, which meant that any effect of day care would be diluted
by the larger proportion of “day patients” who actually received
inpatient care.
2.2.2 Social functioning, burden and satisfaction
The evidence is reasonably strong that social functioning and bur-
den on carers is unaffected by day care, as these data come from
more than one trial and involve reasonably large data sets. How-
ever, the evidence for improved satisfaction is weak, being based
on data from one trial only.
2.3 Costs of care
There are limitations on the interpretation of the cost data caused
by the fact that the trials were conducted at different times, in dif-
ferent countries, using different costing methodologies and pric-
ings. Moreover the costing data calculated for Creed-UK-1990
is an estimate (see method above) based on prices derived from
Creed-UK-1996. On other hand, unsurprisingly, Table 8 shows
that the key cost component is the cost of hospital care. Since all
Type 1 trials achieved a shift of similar magnitude from inpatient
care to day hospital care, it seems likely that all would have reduced
costs - the exact magnitude of this reduction being determined by
the relative pricing of inpatient and day patient care adopted by
the trial. The finding of no difference in costs in the Type 2 trial
Wiersma-NL-1989, does not contradict the cost findings from
Type 1 trials becauseWiersma-NL-1989 assumed, unlike the Type
1 trials, that a day hospital day costs the same as an inpatient day.
3. Applicability of results
A limitation on the applicability of the review is that although
substantial individual patient data was obtained, it was derived
from trials conducted in only three centres (Manchester - Creed-
UK-1990, Creed-UK-1996, New Haven - Sledge-US-1996 and
Groningen - Wiersma-NL-1989). Whilst non-IPD data from the
other included trials generally supports the IPD data, data from a
wider range of centres would enhance confidence in applicability.
Questions about applicability are also raised by the reduction in
rates of loss to followup in the day hospital arms of later trials. This
probably reflects a trend in psychiatric practice towards more per-
sistent follow up of patients who default from care. This change in
practice is not likely to affect the applicability of the findings from
individual patient data as these data are exclusively derived from
the more recent trials, however it may explain the observation by
an earlier reviewer that day hospital care reduces readmission rates
(Moscowitz 1980), i.e. that relapsing patients were lost to follow
up. A further observation with implications for applicability is an
apparent difference in practice between US and UK day hospitals.
Data on duration of index admission (both IPD data and other
aggregate data) suggests that US acute day hospitals are geared
towards intensive treatment and rapid discharge, whereas UK day
hospitals allow a more gradual tailing off of day care. It is unclear
how far this difference has implications for effectiveness or cost.
Inclusion criteria do not appear to be an important limitation on
the applicability of the review. Generally Type 1 trials used simi-
lar explicit inclusion criteria (that exclude involuntary, suicidal or
dangerous patients), with the exceptions of Kris-US-1965 (which
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contributed little data to the meta-analysis) and Creed-UK-1996
(which excluded patients with mania).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Acute day hospitals can achieve substantial reductions in inpatient
care whilst improving patient outcome amongst those suitable for
day hospital care, so it is curious that they are not more popular. In
part this may be due to the difficulties in interpreting day hospital
trials, or the fickleness of psychiatric opinion (see introduction).
On the other hand there are three disadvantages of day hospital
treatment that need to be considered.
1. Day hospital treatment does not appear to be as effective in
reducing admission rates as more radical crisis intervention ap-
proaches.
For example, Assertive Community Treatment, when used to di-
vert patients from hospital, can achieve a 55% reduction in admis-
sions as against the 23% achieved by day hospitals (see Joy 2000
for a systematic review). However, the fact that acute day hospitals
do not involve radical, and perhaps unsustainable, alternations in
psychiatric practice (Joy 2000) needs to be considered.
2. Cost savings achieved by day hospital care are modest
For example, compared with savings of up to 65% reported in
studies of crisis intervention (Marshall 1999), acute day hospital
care (taking a pessimistic estimate) can be expected to achieve a
saving of 4.8% in the costs of acute psychiatric care (calculated
as: cost savings inpatients diverted multiplied by the proportion
of patients diverted, i.e. 20.9 x 0.232, assuming no inpatient beds
were closed).Moreover the cost equationwould appear as yetmore
unfavourable if it were necessary to build the day hospital, rather
than change practice in an existing non-acute day hospital. On the
other hand, so far it has proven difficult to reliably quantify exactly
how much is saved by crisis intervention approaches (Joy 2000).
Moreover, if acute day hospitals proved to be more sustainable
than crisis intervention alternatives, thismightmean that inpatient
beds could actually be closed, thus shifting the cost equation in
favour of day hospital care.
3. It is not clear where day hospitals fit with other types of care
The third disadvantage is that whilst more recent trials (Creed-
UK-1996, Sledge-US-1996) have enhanced day hospital care with
respite or outreach services, it still remains unclear how day hos-
pital care fits together with other types of community care, such
as Assertive Community Treatment or home-based care.
In summary therefore, the decision to establish an acute day hos-
pital must be made after careful consideration of local problems
and resources. Acute day hospitals are an attractive option in situ-
ations where demand for inpatient care is high and facilities exist
that are suitable for conversion. They are a less attractive option in
situations where the demand for inpatient care is low and where
effective alternatives are already in operation.
Implications for research
1.Methodological implications for research on acute day hospitals
1.1 There is a need for a multi-centre randomised controlled trial
to show how far the findings from the present small number of
centres can be more widely replicated.
1.2 The interpretation of day hospital research would be enhanced
if future trials made use of the common set of outcome measures
used in this review.
1.3 Future day hospital trials should take care to report data on
mortality and other untoward events and quality of life.
2. New directions for acute day hospital research
2.1 It would be of interest to explore the relative cost-effectiveness
of the US and UK approaches to acute day hospital care (rapid
discharge versus gradual discharge).
2.2 It would be interesting to examine why patients’ psychiatric
symptoms appear to recover more rapidly in day care (for example,
does hospital admission actually worsen symptoms of depression
or anxiety?).
2.3 It is important to examine how acute day hospital care can
be most effectively integrated into a modern community based
psychiatric service.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Creed-UK-1990
Methods Allocation: randomised, sealed envelope.
Follow up: 3, 12 months.
Evaluation: by rater independent of treating clinician, not blind to group allocation.
Analysis: intention to treat.
Setting: acute day hospital in inner-city Manchester, UK.
Participants Diagnosis: schizophrenia 23.5%, mood disorder 25.4%, other 51%.
Inclusion criteria: i. presenting for inpatient admission, ii. not involuntary patient, iii. not too ill for day
care, iv. no social factors that made day care impractical.
N=102.
Age ~42 years.
Sex: F 44%, M 66%.
History: ethnic ?%, married 39%, unemployed 45%, mean previous admissions 1.8
Interventions 1. Acute day hospital: 8 nurses, 3 OTs. N=51.
2. Routine inpatient. N=51.
Outcomes Lost to follow up.
Readmitted.
Hospital service outcomes: duration index admission (estimated from IPD), inpatient & day patient days/
month (IPD).
Mental state: PSE (IPD).
Social functioning: SBAS Role (IPD).
Burden on relatives: SBAS Burden (IPD).
Costs of hospital care (estimated from IPD).
Unable to use -
Hamilton rating scale: only measured depressive symptoms.
Social behaviour: SBAS behaviour (role functioning used as key indicator of social functioning)
Notes Type 1 trial (IPD obtained).
Loss to follow up: 31%.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Creed-UK-1996
Methods Allocation: randomised, sealed envelope.
Follow up: 0.5, 1, 2, 3, 6, 12 months.
Evaluation: by rater independent of treating clinician, not blind to group allocation.
Analysis: intention to treat.
Setting: acute day hospital in inner-city Manchester, UK.
Participants Diagnosis: schizophrenia 38.5%, mood disorder 30%, other 31.5%.
Inclusion criteria: i. presenting for IP admission ii. 18-65 iii. not involuntary patient iv. not too ill for day
care v. not admission for detox vi. no organic brain disease, personality disorder or mania.
N=187.
Age: mean ~ 38 years.
Sex: F45.5%, M 54.5%
History: ethnic minority 21.5%, married 33%, unemployed 41.5%, mean previous admissions 2.6
Interventions 1. Acute day hospital CPN out of hours. N=94.
2. Routine inpatient. N=93.
Outcomes Lost to follow up.
Readmitted.
Hospital service outcomes: duration index admission (IPD), inpatient & day patient days/month (IPD).
Mental state: CPRS (IPD).
Social functioning: SBAS Role (IPD).
Burden on relatives: SBAS Burden (IPD).
Costs of care (IPD).
Unable to use -
Social behaviour: SBAS behaviour (role functioning used as key indicator of social functioning).
Burden on relatives: GHQ (this is a measure of depression rather than burden, a more extensive measure
of burden from this trial already included (SBAS) - depression in relatives was not an outcome included
in this review
Notes Type 1 trial (IPD obtained).
Loss to follow up: 23.5%.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Dick-UK-1985
Methods Allocation: randomised - no further details.
Follow up: 0, 3, 12 and 52 weeks.
Evaluation: by an independent research psychiatrist, not blind to group allocation.
Analysis: intention to treat.
Setting: acute day hospital in Dundee, UK.
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Dick-UK-1985 (Continued)
Participants Diagnosis: schizophrenia % not known, mood disorder 56%.
Inclusion criteria: i. suitable for day hospital treatment (excluded if too ill, suicidal, or day care impractical)
.
N=91.
Age: mean ~ 35 years
Sex: F 67.6%, M 32.4%
History: ethnic minority % not reported; married 50.4%; unemp 56.6%; mean prev admissions not
known
Interventions 1. Acute day hospital: 2 trained staff + OT, patient /staff ratio: 12.5:1, individual counselling, groups,
activities and medication. N=43.
2. Inpatient care: mixed sex and female wards. N=48.
Outcomes Lost to follow up.
Readmitted.
Satisfaction with care.
Hospital service outcomes: duration of index admission.
Mental state: CIS.
Cost of index admission.
Unable to use -
Continuing medication at one year (not an outcome for this review - unclear whether continuing to take
medication at one year is a good or bad outcome in this population)
Notes Type 1 trial (contacted but IPD no longer exists).
Lost to follow up: 29.6%.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Herz-US-1971
Methods Allocation: randomised by random number table (candidates admitted to inpatient care, then evaluated
and those eligible for day hospital randomly allocated).
Follow up: 0.5, 1, 5, 24 months.
Evaluation: by independent research interviewers, not blind to group allocation.
Analysis: intention to treat.
Setting: acute day hospital in New York State, USA.
Participants Diagnosis: schizophrenia 36%, other 64%.
Inclusion criteria: i. not too ill for day care, ii. not too well for day care, iii. day care impractical.
N=90.
Age: mean ~ 32 years.
Sex: F 59%, M 41%
History: ethnic minority 37%, married 11%, unemployed % unknown, prev admission 49%
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Herz-US-1971 (Continued)
Interventions 1. Acute day hospital: 5 weekdays attendance, 8-4.30pm, group-oriented psychotherapy, patient/staff ratio
not reported. N=45.
2. Routine inpatient care: staff, setting and activities same for both groups. N=45
Outcomes Lost to follow up.
Deaths.
Readmitted.
Hospital service outcomes: duration of index admission.
Unable to use -
Mental state: Psychiatric Evaluation Form, Psychiatric Status Schedule (no summary data)
Notes Type 1 trial (contacted, but IPD no longer exists).
Lost to follow up: 18.8%.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Kris-US-1965
Methods Allocation: randomised at time of relapse.
Follow up: 2 months after discharge.
Evaluation: unclear, but data available only on number of patients in employment.
Analysis: intention to treat .
Setting: acute day hospital in New York, USA.
Participants Diagnosis: not reported, but all had suffered from “psychosis”.
Inclusion criteria: previously treated in hospital for psychotic symptoms.
N=141.
Age: mean unknown.
Sex: F unknown, M unknown.
History: ethnic minority % unknown, married % unknown, unemployed % unknown, mean previous
admissions % unknown
Interventions 1. Acute day hospital: weekdays, 9-5pm, patient/staff ratio not reported, emphasis on milieu & group
therapy. N=71.
2. Standard inpatient treatment. N=70.
Outcomes Employed.
Unable to use -
Hospital service outcomes: days in hospital (mean, SD not reported).
Mental state: Wittenborn rating scale (no data reported).
Notes Type 1 trial (unable to contact).
Lost to follow up: not clear.
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Kris-US-1965 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Schene-NL-1993
Methods Allocation: randomised - no further details, but 14 later withdrawn because of “incorrect randomisation”.
Follow up: at 6 ms following discharge.
Evaluation: unclear if raters independent of treating clinicians, not blind.
Analysis: not intention to treat, see notes.
Lost to follow up: not clear given exclusions.
Setting: Acute day hospital at the University of Utrecht, Netherlands
Participants Diagnosis: precise estimate not possible because of post-randomisation exclusions.
Inclusion criteria: i. referred for inpatient treatment; ii. under 65; iii. no organic brain disease; iv. no
primary diagnosis or substance abuse ormental retardation; v. no other contraindications to day treatment.
N=222.
Demographic composition is uncertain given the exclusions post-randomisation
Interventions 1. Acute day hospital: staff patient ratio 1:12.5, emphasis on psychosocial therapy. N=99.
2. Standard inpatient care: University psychiatric clinic. N=123
Outcomes Lost to follow up.
Unable to use -
Hospital Service Outcomes: days in hospital (not an intention to treat analysis).
Mental state: PSE, SCL-90 (not an intention to treat analysis).
Social Functioning: Groningen Social Disabilities Schedule, Social Network and Social Support Ques-
tionaire (not an intention to treat analysis)
Notes Type 1 trial (no attempt to obtain IPD as not an intention to treat analysis).
Lost to follow up: not clear given exclusions.
Not an intention to treat analysis as 72 patients were excluded after randomisation including any day
patients transferred to a closed ward for more than 28 days
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Sledge-US-1996
Methods Allocation: computer-generated randomisation by a researcher unaware of patient characteristics. (How-
ever, if no bed available candidate was allocated to the other condition).
Follow up: discharge, 2, 5, 10 months.
Evaluation: by rater independent of treating clinician, but not blind to group allocation.
Analysis: intention to treat.
Setting: Day hospital of a community mental health centre day hospital in New Haven, Connecticut,
USA
Participants Diagnosis: schizophrenia 39%, mood disorder 52%, other 9%.
Inclusion criteria: i. >18 years; ii. presenting for IP admission; iii. living locally; iv. not involuntary; v. not
too ill for DP treatment; vi. not intoxicated or medically unwell.
N=197.
Age: mean ~33 years.
Sex: F49% M 51%.
History: ethnic minority 32%, married 13.7%, unemployed 37%, previous admissions - unknown, 52%
previously high service users
Interventions 1. Acute day hospital: crisis respite programme + ’back up’ bed if necessary, day hospital = 20 patient
facility with doctors, nurses, social workers, therapists, weekdays 9-3pm, group work, control of symptoms
& improvement of daily skills. N=93.
2. Inpatient care: 36 bed unit with doctors & nursing staff, psychologist, mental health workers + very
active programme. N=104
Outcomes Lost to follow up.
Readmitted.
Hospital service outcomes: duration of index admission (IPD), inpatient & day patient days/month (IPD)
.
Mental state: BPRS.
Social functioning: SAS.
Costs of care.
Unable to use -
Global functioning: GAS (not an outcome in this review).
Mental state: SCL-90 (redundant measurement - BPRS also used).*
Quality of life: Connecticut Department of Health Quality of Life Survey (unpublished scale).
Satisfaction: Satisfaction with Services Scale (unpublished scale)
Notes Type 1 trial (IPD otained).
Lost to follow up: 28.4%.
* Our IPD analysis required us to choose between the two measure of mental state (BPRS or SCL 90)
used in this study - BPRS was chosen because it was more similar to the CPRS used in the two Creed
studies - the two scales have similar effect sizes in Sledge-US-1996
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
25Day hospital versus admission for acute psychiatric disorders (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Wiersma-NL-1989
Methods Allocation: randomisation - by block using sealed evelope.
Follow-up: 1 and 2 years.
Evaluation: by independent raters who were not blind to group allocation.
Analysis: Intention to treat.
Setting: acute day hospital operated by the Regional Institute for Ambulatory Mental Health Care in
Groningen, Netherlands
Participants Diagnosis: schizophrenia 33.1%, mood disorder 30.1%, other 36.8%. Inclusion criteria: i. presenting for
admission; ii. forensic patients on court order; iii. patients with dementia.
N=160.
Age: mean ~ 42 years.
Sex: F 50%, M 50%.
History: ethnic minority % unknown, married 37.5%, unemployed 89%, prev admissions 61%
Interventions 1. Acute day hospital: admitted as soon as considered no risk to self or others, weekdays 8.30-16.30, could
be inpatient for 1-2 nights on demand, 24 hr on call line to nurse. N=103.
2. Routine inpatient. N=57.
Outcomes Lost to follow up.
Deaths.
Readmitted.
Unemployed.
Hospital service outcomes: days in hospital care (IPD).
Mental state: PSE (IPD).
Social functioning: Groningen Social Disability Scale (IPD).
Notes Type 2 trial (IPD obtained).
Lost to follow up: 41% at 2 years.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Zwerling-US-1964
Methods Allocation: randomisation via list held by phone answering service (fixed ratio).
Follow up - 2 years.
Evaluation: by rater independent of treating clinician, but not blind to group allocation.
Analysis: not an intention to treat analysis patients with organic brain disease were randomised but then
excluded.
Setting: acute day hospital in New York, USA.
Participants Diagnosis: not known.
Inclusion criteria: patients about to be admitted were allocated to day hospital or inpatient treatment.
N=378.
Age: not known.
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Zwerling-US-1964 (Continued)
Sex: F% not known.
History: ethnicminority %not known, married%not known, unemployed%not known, prev admission
% not known
Interventions 1. Acute day hospital: group oriented activities + family therapy, reviewed twice weekly, weekdays. N=
189.
2. Routine inpatient care. N=189.
Outcomes Leaving the study early.
Unable to use -
Deaths (not an intention to treat analysis, people with organic brain disease were excluded from the study
after randomisation).
Readmitted (not an intention to treat analysis, people with organic brain disease were excluded from the
study after randomisation)
Notes Type 2 trial (unable to contact).
Lost to follow up: 8%
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
General abreviations
~ = approximately
CPN = Community Psychiatric Nurse
IPD = individual patient data
OT = Occupational therapist
Scales
BPRS = Brief Psychological Rating Scale
CIS = Clinical Interview Schedule
CPRS = Comprehensive Psychopathological Rating Scale
GAS = Global Assessment Scale
GHQ = General Health Questionnaire
PSE = Present State Examination
SCL 90 = Symptom Check List
SAS = Social Adjustment Scale
SBAS = Social Behaviour Assessment Schedule
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Austin-Los Angeles Allocation: not randomised, survey comparing randomly selected people from two different day hospitals
Azim-Alberta Allocation: not randomised, quasi-experimental design, comparing inpatients, day hospital patients and
non-patient controls
Barkley-Ontario Allocation: not randomised, retrospective study.
Basker-Jerusalem Allocation: not randomised, before and after design.
Bateman-London Allocation: randomised.
Participants: people with personality disorders.
Intervention: care in a psychotherapeutic day hospital versus out-patient care, not acute day hospital care
versus admission
Beigel-New York Allocation: not randomised, quasi-experimental design, comparing people who completed a partial hospi-
talisation program with those who dropped out
Boath-Stoke Allocation: not randomised, quasi-experimental design comparing people in a day treatment program for
post-natal depression with controls in primary care
Bowman-Dublin Allocation: not randomised, survey examining differences between people admitted day hospital and in-
patient care
Bradshaw-Minnesota Allocation: randomised.
Participants: people with schizophrenia who were long term attenders at a day care centre.
Intervention: day care + cognitive behavioural therapy versus day care alone, not acute day hospital care
versus admission
Brook-Denver Allocation: not randomised, survey comparing people treated in a crisis hostel with those treated in inpatient
care
Carey-US Allocation: randomised.
Participants: attenders at a day care centre who also abused substances.
Intervention: problem-solving training + day care versus day care alone, not acute day hospital care versus
admission
Case-New York Allocation: not randomised, retrospective study.
Comstock-Texas Allocation: not randomised, retrospective multivariate analysis
Creed-Blackburn Allocation: randomised by sealed envelope, however, the trialists judged that the randomisation procedure
had been compromised as people allocated to the day hospital condition were much less disabled that those
admitted to inpatient care (available data bear this out in terms of diagnosis and behaviour)
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(Continued)
Creed-Manchester Allocation: not randomised, quasi-experimental study comparing consecutive admission to day hospital
and in-patient care
Dick-Dundee Allocation: randomised.
Participants: patients with chronic anxiety and depression.
Intervention: day hospital versus continuing out-patient care, not acute day hospital care versus admission
Drake-New Hampshire Allocation: not randomised, quasi-experimental design, comparing day treatment with supported employ-
ment program
Ettlinger-New York Allocation: not randomised, case-control study of day hospital versus in-patient care
Fink-Toronto Allocation: not randomised, quasi-experimental study of inpatient care versus day patient care
Glick-New York Allocation: randomised (method not clear).
Participants: people with severe mental illness recently discharged from hospital.
Interventions: transitional day hospital programme versus out patient follow-up, not acute day hospital
care versus admission
Glick-San Francisco Allocation: randomised.
Participants: people requiring hospital in-patient care.
Intervention: short versus long hospital admission, not acute day hospital care versus admission
Grad-Chichester Allocation: not randomised, quasi-experimental design comparing community care in two towns
Gudeman-Boston Allocation: not randomised, before and after design.
Guidry-New Orleans Allocation: not randomised, before and after design.
Guillette-Maryland Allocation: not randomised, survey comparing costs of day patient care with theoretical costs of inpatient
care
Guy-Baltimore Allocation: randomised by sealed envelope.
Participants: people with a variety of psychiatric disorders referred for day care.
Intervention: day hospital treatment versus out patient care, not acute day hospital care versus admission
Herz-New York2 Allocation: randomised (method not specified).
Participants: people with acute psychiatric disorders about to be admitted to inpatient care.
Interventions: routine inpatient care versus brief inpatient care versus brief inpatient plus day care, not
acute day hospital care versus admission
Hirsch-London Allocation: random allocation (method not specified).
Participants: people with acute psychiatric disorders about to be admitted to inpatient care.
Interventions: brief inpatient care with some use of day hospital (47% patients in the brief care group were
exposed to day hospital) versus routine inpatient care, not acute day hospital care versus admission
Hogg-Glasgow Allocation: not randomised, a survey comparing long term inpatients with long term day patients
29Day hospital versus admission for acute psychiatric disorders (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Inch-Saskatchewan Allocation: not randomised, a prospective study comparing day hospital patients receiving ’therapeutic’
and ’non-therapeutic’ discharges
Jarema-Warsaw Allocation: not randomised, a survey comparing quality of life scores between day hospital patients, in-
patients and out-patients
Kandel-US Allocation: randomised.
Participants: adult general psychiatry patients attending a day treatment program.
Intervention: day treatment plus a small group intervention compared against day treatment, in order to
assess effect on “future time perception”, not acute day hospital care versus admission
Kecmanovic-Sarajevo Allocation: not randomised, case-control study comparing discharged inpatients with discharged day pa-
tients
Klyczek-US Allocation: not randomised, quasi-experimental design comparing outcome in two day hospitals, one of
which offered mainly psychotherapy, whilst the other offered mainly activity therapy
Konieczynska-Warsaw Allocation: not randomised, follow up study comparing the outcome for patients treated in a day hospital,
in-patient ward and community mental health team
Kuldau-California Allocation: randomised
Participants: inpatients about to be discharged.
Interventions: rapid discharge from inpatient care versus community transitional system (34%subjects of
intervention group were discharged via day hospital), not acute day hospital care versus admission
Levenson-Houston Allocation: randomised by table of random numbers.
Participants: people with acute schizophrenia.
Intervention: treatment in an outpatient clinic versus hospital admission, excluded as outpatient clinic
does not meet criteria for day hospital
Liang-Taipei Allocation: not randomised, a survey comparing quality of life in patients in various care settings, including
day hospitals
Linn-USA Allocation: randomised by sealed envelope.
Participants: people with schizophrenia about to be discharged from hospital.
Interventions: day hospital treatment or out patient care, not acute day hospital care versus admission
Lystad-Louisiana Allocation: not randomised, quasi-experimental design.
Mathai-Bangalore Allocation: not randomised, survey.
Meltzoff-New York Allocation: randomised by sealed evelope.
Participants: people with a variety of mental disorders referred for day care.
Interventions: day hospital treatment versus outpatient care, not acute day hospital care versus admission
Michaux-Maryland Allocation: not randomised, quasi-experimental study of inpatient care versus day hospital care
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Milne-Wakefield Allocation: not randomised, quasi-experimental study.
Niskanen-Helsinki Allocation: not randomised, compared patients before and after treatment in a day hospital
O’Shea-Ireland Allocation: not randomised, retrospective cost-effectiveness analysis comparing day patients and in-patients
Odenheimer-USA Allocation: not randomised, survey of the relatives of day hospital patients
Oka-Kurume-Japan Allocation: not randomised, quasi-experimental design comparing outcome in 31 patients with schizophre-
nia entering a day care centre with that of 30 out-patients with schizophrenia matched for age and sex
Penk-Dallas Allocation: not randomised, case-control study of day hospital versus inpatient care
Piersma-Michigan Allocation: not randomised, quasi-experimental study compared improvement in a group of in-patients
with that in a group in day hospital
Piper-Alberta Allocation: randomised.
Participants: outpatients with affective and personality disorders.
Intervention: outpatient treatment of day hospital care, not acute day hospital care versus admission
Platt-London Allocation: randomised.
Participants: people with acute psychiatric disorders
Intervention: admission to day hospital versus inpatient care, trial abandoned when insufficient people
(10) were randomised in first 10 weeks. No data available
Russell-Ottawa Allocation: not randomised, outcome for day patients compared with a retrospectively obtained sample of
in-patients
Sandell-Stockholm Allocation: not randomised, cohort study.
Tam-Hong Kong Allocation: not randomised, survey comparing day patients with in-patients on demographic and psycho-
logical variables
Tantam-Manchester Allocation: not randomised, case-control study of a rehabilitation treatment for long-stay day patients
Tyrer-Southampton Allocation: randomised by sealed envelope.
Participants: people with depression and anxiety.
Interventions: out patient treatment versus two varieties of day care, not acute day hospital care versus
admission
Vaglum-Oslo Allocation: not randomised, follow up study comparing outcome in day patients with different types of
personality disorder
Vaitl-Haar-Germany Allocation: not randomised, retrospective study comparing outcome in patients treated at day hospitals
with those treated at “night” hospitals
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van den Hout-NL Allocation: randomised.
Participants: depressed patients on a day treatment program.
Intervention: self-control therapy plus day care versus day care, not acute day hospital care versus admission
Washburn-Boston Allocation: randomised, method not specified.
Participants: women receiving inpatient treatment.
Intervention: continuing inpatient admission versus discharge to day patient care, not acute day hospital
care versus admission
Welburn-Ottawa Allocation: not randomised, quasi-experimental design in which outcome for patients participating in a
psychotherapy-oriented day treatment program was compared against outcome for those awaiting admis-
sion to the program
Weldon-New York Allocation: randomised, method not specified.
Participants: people about to be discharged from inpatient care.
Intervention: day hospital treatment versus out patient care, not acute day hospital care versus admission
Wilberg-Oslo Allocation: not randomised, quasi-experimental study of day treatment + psychotherapy versus day treat-
ment alone, for people with borderline personality disorder
Characteristics of ongoing studies [ordered by study ID]
Priebe-UK-2000
Trial name or title Not known.
Methods
Participants People with acute psychiatric disorders.
Interventions 1. Acute day hospital treatment.
2. Routine inpatient care.
Outcomes Clinical.
Social.
Economic.
(1 week, discharge, at 3 months, 1 year follow-up.)
Starting date In progress.
3 year project.
Contact information Professor Stephan Priebe
Chair of Social and Community Psychiatry
East Ham Memorial Hospital
London
E-mail: s.priebe@qmw.ac.uk
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Notes Funding: NHS Executive.
The study has joined a European multi-centred project evaluating similar services in Prague (Czech Republic)
, Dresden (Germany), Wroclaw (Poland), and Michalovce (Slovakia)
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D A T A A N D A N A L Y S E S
Comparison 1. DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before randomisation)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Feasibility and engagement: Lost
to follow up (at end of study)
5 667 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.74, 1.27]
1.1 by 6 months 1 90 Risk Ratio (M-H, Fixed, 95% CI) 1.57 [0.67, 3.69]
1.2 by about 1 year 4 577 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.68, 1.21]
2 Extent of hospital care: 1.
Duration of index admission
(IPD)
3 465 Mean Difference (IV, Fixed, 95% CI) 10.90 [1.09, 20.70]
3 Extent of hospital care: 2.
Duration of all hospital care
(days/month, IPD)
3 465 Mean Difference (IV, Fixed, 95% CI) -0.38 [-1.32, 0.55]
4 Extent of hospital care: 3.
Duration of day patient care
(adjusted days/month, IPD)
3 465 Mean Difference (IV, Fixed, 95% CI) 2.34 [1.97, 2.70]
5 Extent of hospital care: 4.
Duration of stay in hospital
(days/month, IPD)
3 465 Mean Difference (IV, Fixed, 95% CI) -2.75 [-3.63, -1.87]
6 Extent of hospital care: 5.
Readmitted to in/day patient
care after discharge
5 667 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.72, 1.15]
7 Burden: Average carers’ score
(SBAS, high = poor, IPD)
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
7.1 at 14 days 1 85 Mean Difference (IV, Fixed, 95% CI) 0.27 [-2.58, 3.12]
7.2 at 1 month 1 95 Mean Difference (IV, Fixed, 95% CI) -0.04 [-2.54, 2.46]
7.3 at 2 months 1 95 Mean Difference (IV, Fixed, 95% CI) 0.65 [-1.33, 2.63]
7.4 at 3 months 2 160 Mean Difference (IV, Fixed, 95% CI) -0.59 [-1.62, 0.44]
7.5 at 12 months 1 65 Mean Difference (IV, Fixed, 95% CI) -0.69 [-2.14, 0.76]
8 Death (all causes) 1 90 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 7.97]
9 Unemployed (at end of study) 1 179 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.66, 1.19]
10 Not satisfied with care received 1 91 Risk Ratio (M-H, Fixed, 95% CI) 0.46 [0.27, 0.79]
Comparison 2. DAY PATIENT vs INPATIENT (Type 2 trials, all presenting for admission were randomised)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Feasibility and engagement: Lost
to follow up (at 2 years)
1 160 Risk Ratio (M-H, Fixed, 95% CI) 0.69 [0.48, 0.99]
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2 Extent of hospital care: 1.
Duration of all hospital care
(days/month, IPD - ”nights in”
& ”nights out”)
1 160 Mean Difference (IV, Fixed, 95% CI) 1.10 [-1.58, 3.78]
3 Extent of hospital care: 2.
Readmitted to in/day patient
care after discharge
1 160 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.64, 1.35]
4 Mental state: Average endpoint
score (PSE 9, high=poor, IPD)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
4.1 At baseline 1 114 Mean Difference (IV, Fixed, 95% CI) 0.54 [-4.33, 5.41]
4.2 At 12 months 1 81 Mean Difference (IV, Fixed, 95% CI) 1.87 [-2.89, 6.63]
4.3 At 24 months 1 85 Mean Difference (IV, Fixed, 95% CI) 2.19 [-1.00, 7.38]
5 Social functioning: Average
overall role score (Groningen
Scale, IPD)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
5.1 At baseline 1 106 Mean Difference (IV, Fixed, 95% CI) -0.11 [-0.45, 0.23]
5.2 At 12 months 1 95 Mean Difference (IV, Fixed, 95% CI) -0.25 [-0.62, 0.12]
5.3 At 24 months 1 95 Mean Difference (IV, Fixed, 95% CI) -0.19 [-0.58, 0.20]
6 Death (all causes) 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
6.1 Deaths (suicide and
untoward events)
1 160 Risk Ratio (M-H, Fixed, 95% CI) 2.79 [0.14, 57.10]
6.2 Deaths (other causes) 1 160 Risk Ratio (M-H, Fixed, 95% CI) 0.37 [0.06, 2.14]
6.3 Deaths all causes 1 160 Risk Ratio (M-H, Fixed, 95% CI) 0.74 [0.17, 3.18]
7 Unemployed (at end of study) 1 160 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.87, 1.04]
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Analysis 1.1. Comparison 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before
randomisation), Outcome 1 Feasibility and engagement: Lost to follow up (at end of study).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before randomisation)
Outcome: 1 Feasibility and engagement: Lost to follow up (at end of study)
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 by 6 months
Herz-US-1971 11/45 7/45 8.7 % 1.57 [ 0.67, 3.69 ]
Subtotal (95% CI) 45 45 8.7 % 1.57 [ 0.67, 3.69 ]
Total events: 11 (Day patients), 7 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 1.04 (P = 0.30)
2 by about 1 year
Dick-UK-1985 5/43 3/48 3.5 % 1.86 [ 0.47, 7.33 ]
Creed-UK-1990 19/51 13/51 16.1 % 1.46 [ 0.81, 2.63 ]
Creed-UK-1996 23/94 23/93 28.6 % 0.99 [ 0.60, 1.63 ]
Sledge-US-1996 19/93 37/104 43.2 % 0.57 [ 0.36, 0.93 ]
Subtotal (95% CI) 281 296 91.3 % 0.91 [ 0.68, 1.21 ]
Total events: 66 (Day patients), 76 (Hospital admission)
Heterogeneity: Chi2 = 7.21, df = 3 (P = 0.07); I2 =58%
Test for overall effect: Z = 0.65 (P = 0.52)
Total (95% CI) 326 341 100.0 % 0.97 [ 0.74, 1.27 ]
Total events: 77 (Day patients), 83 (Hospital admission)
Heterogeneity: Chi2 = 8.60, df = 4 (P = 0.07); I2 =53%
Test for overall effect: Z = 0.24 (P = 0.81)
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Analysis 1.2. Comparison 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before
randomisation), Outcome 2 Extent of hospital care: 1. Duration of index admission (IPD).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before randomisation)
Outcome: 2 Extent of hospital care: 1. Duration of index admission (IPD)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Creed-UK-1990 41 101.6 (82.8) 48 46.1 (62.9) 10.0 % 55.50 [ 24.53, 86.47 ]
Creed-UK-1996 90 91.6 (78.6) 89 55.8 (58.2) 23.5 % 35.80 [ 15.55, 56.05 ]
Sledge-US-1996 93 31.8 (44) 104 36.4 (41.8) 66.5 % -4.60 [ -16.62, 7.42 ]
Total (95% CI) 224 241 100.0 % 10.90 [ 1.09, 20.70 ]
Heterogeneity: Chi2 = 20.17, df = 2 (P = 0.00004); I2 =90%
Test for overall effect: Z = 2.18 (P = 0.029)
Test for subgroup differences: Not applicable
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Analysis 1.3. Comparison 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before
randomisation), Outcome 3 Extent of hospital care: 2. Duration of all hospital care (days/month, IPD).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before randomisation)
Outcome: 3 Extent of hospital care: 2. Duration of all hospital care (days/month, IPD)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Creed-UK-1990 41 5.8 (4.65) 48 5.41 (5.96) 17.9 % 0.39 [ -1.82, 2.60 ]
Creed-UK-1996 90 4.31 (4.97) 89 5.42 (5.29) 38.5 % -1.11 [ -2.61, 0.39 ]
Sledge-US-1996 93 5.08 (4.97) 104 5.14 (5.13) 43.7 % -0.06 [ -1.47, 1.35 ]
Total (95% CI) 224 241 100.0 % -0.38 [ -1.32, 0.55 ]
Heterogeneity: Chi2 = 1.57, df = 2 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 0.81 (P = 0.42)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before
randomisation), Outcome 4 Extent of hospital care: 3. Duration of day patient care (adjusted days/month,
IPD).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before randomisation)
Outcome: 4 Extent of hospital care: 3. Duration of day patient care (adjusted days/month, IPD)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Creed-UK-1990 41 4.35 (3.82) 48 0.75 (2.13) 7.7 % 3.60 [ 2.28, 4.92 ]
Creed-UK-1996 90 3.45 (3.1) 89 0.73 (1.84) 24.0 % 2.72 [ 1.97, 3.47 ]
Sledge-US-1996 93 2.85 (1.65) 104 0.79 (1.5) 68.3 % 2.06 [ 1.62, 2.50 ]
Total (95% CI) 224 241 100.0 % 2.34 [ 1.97, 2.70 ]
Heterogeneity: Chi2 = 6.06, df = 2 (P = 0.05); I2 =67%
Test for overall effect: Z = 12.54 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before
randomisation), Outcome 5 Extent of hospital care: 4. Duration of stay in hospital (days/month, IPD).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before randomisation)
Outcome: 5 Extent of hospital care: 4. Duration of stay in hospital (days/month, IPD)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Creed-UK-1990 41 1.44 (3.83) 48 4.67 (5.79) 19.0 % -3.23 [ -5.24, -1.22 ]
Creed-UK-1996 90 1.7 (4.43) 89 4.91 (5.19) 38.6 % -3.21 [ -4.62, -1.80 ]
Sledge-US-1996 93 2.24 (4.89) 104 4.35 (4.75) 42.4 % -2.11 [ -3.46, -0.76 ]
Total (95% CI) 224 241 100.0 % -2.75 [ -3.63, -1.87 ]
Heterogeneity: Chi2 = 1.49, df = 2 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 6.13 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before
randomisation), Outcome 6 Extent of hospital care: 5. Readmitted to in/day patient care after discharge.
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before randomisation)
Outcome: 6 Extent of hospital care: 5. Readmitted to in/day patient care after discharge
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Creed-UK-1990 8/51 18/51 17.4 % 0.44 [ 0.21, 0.93 ]
Creed-UK-1996 25/94 20/93 19.4 % 1.24 [ 0.74, 2.07 ]
Dick-UK-1985 8/43 10/48 9.1 % 0.89 [ 0.39, 2.06 ]
Herz-US-1971 15/45 20/45 19.3 % 0.75 [ 0.44, 1.27 ]
Sledge-US-1996 36/93 38/104 34.7 % 1.06 [ 0.74, 1.52 ]
Total (95% CI) 326 341 100.0 % 0.91 [ 0.72, 1.15 ]
Total events: 92 (Day patients), 106 (Hospital admission)
Heterogeneity: Chi2 = 6.21, df = 4 (P = 0.18); I2 =36%
Test for overall effect: Z = 0.78 (P = 0.44)
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Analysis 1.7. Comparison 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before
randomisation), Outcome 7 Burden: Average carers’ score (SBAS, high = poor, IPD).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before randomisation)
Outcome: 7 Burden: Average carers’ score (SBAS, high = poor, IPD)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 at 14 days
Creed-UK-1996 41 9.32 (7.19) 44 9.05 (6.11) 100.0 % 0.27 [ -2.58, 3.12 ]
Subtotal (95% CI) 41 44 100.0 % 0.27 [ -2.58, 3.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.19 (P = 0.85)
2 at 1 month
Creed-UK-1996 46 7.74 (7.03) 49 7.78 (5.22) 100.0 % -0.04 [ -2.54, 2.46 ]
Subtotal (95% CI) 46 49 100.0 % -0.04 [ -2.54, 2.46 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.03 (P = 0.98)
3 at 2 months
Creed-UK-1996 50 6.18 (5.46) 45 5.53 (4.36) 100.0 % 0.65 [ -1.33, 2.63 ]
Subtotal (95% CI) 50 45 100.0 % 0.65 [ -1.33, 2.63 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.64 (P = 0.52)
4 at 3 months
Creed-UK-1990 32 2.81 (2.32) 34 3.53 (2.72) 71.7 % -0.72 [ -1.94, 0.50 ]
Creed-UK-1996 48 5.06 (4.77) 46 5.33 (4.81) 28.3 % -0.27 [ -2.21, 1.67 ]
Subtotal (95% CI) 80 80 100.0 % -0.59 [ -1.62, 0.44 ]
Heterogeneity: Chi2 = 0.15, df = 1 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 1.13 (P = 0.26)
5 at 12 months
Creed-UK-1990 32 2.22 (2.37) 33 2.91 (3.49) 100.0 % -0.69 [ -2.14, 0.76 ]
Subtotal (95% CI) 32 33 100.0 % -0.69 [ -2.14, 0.76 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.93 (P = 0.35)
Test for subgroup differences: Chi2 = 1.65, df = 4 (P = 0.80), I2 =0.0%
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Analysis 1.8. Comparison 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before
randomisation), Outcome 8 Death (all causes).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before randomisation)
Outcome: 8 Death (all causes)
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Herz-US-1971 0/45 1/45 100.0 % 0.33 [ 0.01, 7.97 ]
Total (95% CI) 45 45 100.0 % 0.33 [ 0.01, 7.97 ]
Total events: 0 (Day patients), 1 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
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Analysis 1.9. Comparison 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before
randomisation), Outcome 9 Unemployed (at end of study).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before randomisation)
Outcome: 9 Unemployed (at end of study)
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Creed-UK-1996 42/90 47/89 100.0 % 0.88 [ 0.66, 1.19 ]
Total (95% CI) 90 89 100.0 % 0.88 [ 0.66, 1.19 ]
Total events: 42 (Day patients), 47 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 0.82 (P = 0.41)
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Analysis 1.10. Comparison 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded
before randomisation), Outcome 10 Not satisfied with care received.
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 DAY PATIENT vs INPATIENT (Type 1 trials, unsuitable people excluded before randomisation)
Outcome: 10 Not satisfied with care received
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Dick-UK-1985 12/43 29/48 100.0 % 0.46 [ 0.27, 0.79 ]
Total (95% CI) 43 48 100.0 % 0.46 [ 0.27, 0.79 ]
Total events: 12 (Day patients), 29 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 2.84 (P = 0.0044)
0.1 0.2 0.5 1 2 5 10
Favours day patients Favours inpatients
Analysis 2.1. Comparison 2 DAY PATIENT vs INPATIENT (Type 2 trials, all presenting for admission were
randomised), Outcome 1 Feasibility and engagement: Lost to follow up (at 2 years).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 2 DAY PATIENT vs INPATIENT (Type 2 trials, all presenting for admission were randomised)
Outcome: 1 Feasibility and engagement: Lost to follow up (at 2 years)
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wiersma-NL-1989 36/103 29/57 100.0 % 0.69 [ 0.48, 0.99 ]
Total (95% CI) 103 57 100.0 % 0.69 [ 0.48, 0.99 ]
Total events: 36 (Day patients), 29 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 2.01 (P = 0.045)
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Analysis 2.2. Comparison 2 DAY PATIENT vs INPATIENT (Type 2 trials, all presenting for admission were
randomised), Outcome 2 Extent of hospital care: 1. Duration of all hospital care (days/month, IPD - “nights in”
& “nights out”).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 2 DAY PATIENT vs INPATIENT (Type 2 trials, all presenting for admission were randomised)
Outcome: 2 Extent of hospital care: 1. Duration of all hospital care (days/month, IPD - ”nights in” % ”nights out”)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Wiersma-NL-1989 103 7.48 (8.39) 57 6.38 (8.22) 100.0 % 1.10 [ -1.58, 3.78 ]
Total (95% CI) 103 57 100.0 % 1.10 [ -1.58, 3.78 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.80 (P = 0.42)
Test for subgroup differences: Not applicable
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Analysis 2.3. Comparison 2 DAY PATIENT vs INPATIENT (Type 2 trials, all presenting for admission were
randomised), Outcome 3 Extent of hospital care: 2. Readmitted to in/day patient care after discharge.
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 2 DAY PATIENT vs INPATIENT (Type 2 trials, all presenting for admission were randomised)
Outcome: 3 Extent of hospital care: 2. Readmitted to in/day patient care after discharge
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wiersma-NL-1989 42/103 25/57 100.0 % 0.93 [ 0.64, 1.35 ]
Total (95% CI) 103 57 100.0 % 0.93 [ 0.64, 1.35 ]
Total events: 42 (Day patients), 25 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 0.38 (P = 0.70)
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Analysis 2.4. Comparison 2 DAY PATIENT vs INPATIENT (Type 2 trials, all presenting for admission were
randomised), Outcome 4 Mental state: Average endpoint score (PSE 9, high=poor, IPD).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 2 DAY PATIENT vs INPATIENT (Type 2 trials, all presenting for admission were randomised)
Outcome: 4 Mental state: Average endpoint score (PSE 9, high=poor, IPD)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 At baseline
Wiersma-NL-1989 77 21.3 (12.48) 37 20.76 (12.38) 100.0 % 0.54 [ -4.33, 5.41 ]
Subtotal (95% CI) 77 37 100.0 % 0.54 [ -4.33, 5.41 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.22 (P = 0.83)
2 At 12 months
Wiersma-NL-1989 55 12.49 (12.93) 26 10.62 (8.62) 100.0 % 1.87 [ -2.89, 6.63 ]
Subtotal (95% CI) 55 26 100.0 % 1.87 [ -2.89, 6.63 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.77 (P = 0.44)
3 At 24 months
Wiersma-NL-1989 60 10.55 (11.45) 25 8.36 (10.98) 100.0 % 2.19 [ -3.00, 7.38 ]
Subtotal (95% CI) 60 25 100.0 % 2.19 [ -3.00, 7.38 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.83 (P = 0.41)
Test for subgroup differences: Chi2 = 0.24, df = 2 (P = 0.89), I2 =0.0%
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Analysis 2.5. Comparison 2 DAY PATIENT vs INPATIENT (Type 2 trials, all presenting for admission were
randomised), Outcome 5 Social functioning: Average overall role score (Groningen Scale, IPD).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 2 DAY PATIENT vs INPATIENT (Type 2 trials, all presenting for admission were randomised)
Outcome: 5 Social functioning: Average overall role score (Groningen Scale, IPD)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 At baseline
Wiersma-NL-1989 74 2.42 (0.81) 32 2.53 (0.84) 100.0 % -0.11 [ -0.45, 0.23 ]
Subtotal (95% CI) 74 32 100.0 % -0.11 [ -0.45, 0.23 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.63 (P = 0.53)
2 At 12 months
Wiersma-NL-1989 67 2.21 (0.86) 28 2.46 (0.84) 100.0 % -0.25 [ -0.62, 0.12 ]
Subtotal (95% CI) 67 28 100.0 % -0.25 [ -0.62, 0.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.31 (P = 0.19)
3 At 24 months
Wiersma-NL-1989 67 2.06 (0.87) 28 2.25 (0.89) 100.0 % -0.19 [ -0.58, 0.20 ]
Subtotal (95% CI) 67 28 100.0 % -0.19 [ -0.58, 0.20 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.95 (P = 0.34)
Test for subgroup differences: Chi2 = 0.30, df = 2 (P = 0.86), I2 =0.0%
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Analysis 2.6. Comparison 2 DAY PATIENT vs INPATIENT (Type 2 trials, all presenting for admission were
randomised), Outcome 6 Death (all causes).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 2 DAY PATIENT vs INPATIENT (Type 2 trials, all presenting for admission were randomised)
Outcome: 6 Death (all causes)
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Deaths (suicide and untoward events)
Wiersma-NL-1989 2/103 0/57 100.0 % 2.79 [ 0.14, 57.10 ]
Subtotal (95% CI) 103 57 100.0 % 2.79 [ 0.14, 57.10 ]
Total events: 2 (Day patients), 0 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.51)
2 Deaths (other causes)
Wiersma-NL-1989 2/103 3/57 100.0 % 0.37 [ 0.06, 2.14 ]
Subtotal (95% CI) 103 57 100.0 % 0.37 [ 0.06, 2.14 ]
Total events: 2 (Day patients), 3 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 1.11 (P = 0.27)
3 Deaths all causes
Wiersma-NL-1989 4/103 3/57 100.0 % 0.74 [ 0.17, 3.18 ]
Subtotal (95% CI) 103 57 100.0 % 0.74 [ 0.17, 3.18 ]
Total events: 4 (Day patients), 3 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 0.41 (P = 0.68)
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Analysis 2.7. Comparison 2 DAY PATIENT vs INPATIENT (Type 2 trials, all presenting for admission were
randomised), Outcome 7 Unemployed (at end of study).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 2 DAY PATIENT vs INPATIENT (Type 2 trials, all presenting for admission were randomised)
Outcome: 7 Unemployed (at end of study)
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wiersma-NL-1989 93/103 54/57 100.0 % 0.95 [ 0.87, 1.04 ]
Total (95% CI) 103 57 100.0 % 0.95 [ 0.87, 1.04 ]
Total events: 93 (Day patients), 54 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 1.07 (P = 0.28)
0.5 0.7 1 1.5 2
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A D D I T I O N A L T A B L E S
Table 1. Feasibility and engagement: 1. Proportion suitable for day hospital (Type 1)
Study Eligible
(pess)
Eligible
(opt)
Ran-
domised
Rand day
hosp
Rand & en-
gaged
% feasible
(opt)
% feasible
(pess)
Kris-US-65 ? ? not applica-
ble
not applica-
ble
? ? ? (see text)
Herz-US-71 424 310 90 45 35 29.0 16.5
Dick-UK-
85
334 203 75 43 37 36.9 19.3
Creed-UK-
90
185 175 102 51 35 58.3 37.8
Schene-NL-
93
534 534 199 ? ? 37.3 ? (see text)
Creed-UK-
96
? ? not applica-
ble
not applica-
ble
? ? ? (see text)
Sledge-US-
96
791 546 197 93 93 36.1 24.9
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Table 1. Feasibility and engagement: 1. Proportion suitable for day hospital (Type 1) (Continued)
Overall type
1
2268 1768 663 232 200 37.5 (95%
CI 35.2-39.
8)
23.2 (95%
CI 21.2-25.
2)
Table 2. Feasibility and engagement: 2. Proportion suitable for day hospital (Type 2)
Study Eligible Randomised Rand day hosp Mainly in DH % feasible
Wiersma-NL-89 160 160 103 19 18.4
Zwerling-US-64 278 189 189 74 39.1
Table 3. Extent of hospital care: Duration of index admission (Type 1 additional data)
Study Duration day patient Duration in patient Notes
Dick-UK-1985 median 34 days median 20 days after adjustment
Herz-US-1971 mean 48.5 days mean 138.8 days no statistical test reported
Table 4. Type 1 trials: Data schedule for individual patient data.
Trial Mental State Social Functioning
Creed-UK-1990 0, 3 & 12 months 0, 3 & 12 months
Creed-UK-1996 0, 6 & 12 months 0, 0.5, 1, 2, 3, 6 & 12 months
Sledge-US-1996 2, 5 & 10 months 0, 2, 5&10 months
Table 5. Type 1 trials: Summary of covariates used in the individual patient analysis.
Co-variate Creed 1990 (IP) Creed 1990
(DP)
Creed 1996 (IP) Creed 1996
(DP)
Sledge 1996
(IP)
Sledge 1996
(DP)
N Randomised 51 51 93 94 104 93
N Included in
analysis
47 40 84 84 98 91
Males (%) 26 (55) 23 (58) 45 (54) 46 (55) 56 (57) 42 (46)
Females (%) 21 (45) 17 (42) 39 (46) 38 (45) 42 (43) 49 (54)
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Table 5. Type 1 trials: Summary of covariates used in the individual patient analysis. (Continued)
<24 yrs 2 (4) 4 (10) 14 (17) 14 (17) 15 (15) 15 (16)
25-34 20 (42) 10 (25) 23 (27) 24 (28) 43 (44) 42 (46)
35-44 7 (15) 6 (15) 25 (30) 17 (20) 23 (23) 20 (22)
45-54 8 (17) 7 (18) 13 (15) 9 (11) 10 (10) 11 (12)
>55 10 (21) 13 (32) 9 (11) 20 (24) 7 (7) 3 (3)
Bipolar or Scz 18 (38) 14 (35) 40 (48) 31 (40) 56 (57) 46 (50)
Other diagnosis 29 (62) 26 (65) 44 (52) 53 (60) 42 (43) 45 (49)
Table 6. Mental state: Model coefficients for standardised mental state scores
Parameters Model Coeff. (SE) 95% CI p value
FIXED EFFECTS
Time Intervention Interaction
(months)
-0.007 (0.0022) -0.011 to -0.002 0.002
Time (months) -0.073 (0.0067) -0.086 to -0.059
Gender (0=female, 1= male) 0.018 (0.0642) -0.110 to 0.147 0.777
Diagnosis (0=other, 1 = scz or
bpd)
0.054 (0.0648) -0.076 to 0.184 0.406
Age 0.019 (0.1124) -0.206 to 0.244 0.862
Study 2 (Creed-UK-1996) -0.046 (0.0899) -0.225 to 0.134
Study 3 (Sledge-US-1996) 0.084 (0.0948) -0.106 to 0.273 0.189
Intervention group 0.144 (0.0671) 0.009 to 0.278 0.032
Constant 0.229 (0.1303) -0.026 to 0.485
RANDOMEFFECTS (patient
level)
Constant (intercept) 0.211 (0.0324) n/a
Constant*time (weeks) 0.001 (0.0007) n/a
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Table 6. Mental state: Model coefficients for standardised mental state scores (Continued)
Time gradient (weeks) 0.00008 (0.00003) n/a
RANDOM EFFECTS (time
level)
Constant (error) 0.508 (0.0225) n/a
Table 7. Costs of care: 1. Raw data (Type 1 trials)
Trial Index Ad.
(DP)
Index Ad.
(IP)
Hosp. Care
(DP)
Hosp. Care
(IP)
All Psy Care
(DP)
All Psy Care
(IP)
Total cost
(DP)
Total cost
(IP)
Dick-UK-
1985
£307.3 £610.0 Not known Not known Not known Not known Not known Not known
Creed-UK-
1990
Not known Not known £4847
(3310-
6384)
£6396
(4277-
8515)
Not known Not known Not known Not known
Creed-UK-
1996
Not known Not known £4101
(2852-
5351)
£6809
(5388-
8231)
£4653
(3339-
5966)
£7379
(5886-
8872)
£5695
(2483-
8907)
£7487
(5339-
9636)
Sledge-US-
1996
$13239
(9189-
17288)
$19903
(15906-
23899)
$24376
(18567-
30186)
$30747
(24904-
36590)
$26819
(20933-
32705)
$33916
(27940-
39893)
Not known Not known
Table 8. Costs of care: 2. Percent differences in costs (Type 1 trials)
Trial Index Admission Hospital care All psychiatric care All costs care
Dick-UK-1985 -49.6% (no test) Not known Not known Not known
Creed-UK-1990 Not known -24.2% (p=0.675) Not known Not known
Creed-UK-1996 Not known -39.8% (p<0.001) -36.9% (p<0.001) -23.9% (p=0.014)
Sledge-US-1996 -33.5% (p<0.001) -20.7% (p=0.012) -20.9% (p=0.009) Not known
- indicates DH is cheaper Mann Whitney Tests
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Table 9. Costs of care: 3. Raw data (Type 2 trials)
Trial Hosp. care (DP) Hosp. care (IP) All Psy Care (DP) All Psy Care (IP)
Wiersma-NL-1989 Dfl 43928 (33535-
54319)
Dfl 35990 (23375-
48604)
Dfl 48377 (38005-
58748)
Dfl 38252 (25684-
50821)
Table 10. Costs of care: 4. Percent differences in costs (Type 2 trials)
Trial Hospital care All psychiatric care
Wiersma-NL-1989 +22.0% (p=0.175) +26.4% (p=0.057)
+ indicates DH is more expensive
WH A T ’ S N E W
Last assessed as up-to-date: 16 November 2002.
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H I S T O R Y
Protocol first published: Issue 1, 1999
Review first published: Issue 1, 2003
Date Event Description
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22 October 2008 Amended Converted to new review format.
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